Евразийские клинические рекомендации по питанию при сердечно-сосудистых заболеваниях (2024)

В рекомендациях изложены современные представления о здоровом питании, основных принципах диетического лечебного и профилактического питания пациентов с различными сердечно-сосудистыми заболеваниями. Представлены наиболее значимые особенности пищевого статуса, обоснованы подходы к немедикаментозному лечению, диетотерапии, с учетом патогенетических основ заболевания. В работе суммированы современные представления и рекомендации по питанию пациентов с артериальной гипертензией, ишемической болезнью сердца, хронической сердечной недостаточностью, нарушениями сердечного ритма, дислипидемиями и подагрой. Особое внимание уделено диетотерапии пациентов с сердечно-сосудистой патологией, страдающих ожирением и сахарным диабетом.

1. Федеральный закон от 01.03.2020 № 47-ФЗ «О внесении изменений в Федеральный закон «О качестве и безопасности пищевых продуктов» и Статью 37 Федерального закона «Об образовании в Российской Федерации РФ».

2. Методические рекомендации МР 2.3.1.0253-21 «Нормы физиологических потребностей в энергии и пищевых веществах для различных групп населения Российской Федерации», Москва, 2021, 72 стр. https://www.rospotrebnadzor.ru/documents/details.php?ELEMENT_ID=18979 (31 August 2024)

3. Устойчивое здоровое питание. Руководящие принципы. ФАО, ВОЗ. Рим, 2020, 44 стр. https://doi.org/10.4060/ca6640ru (31 August 2024)

4. Minimum dietary diversity for women. FAO. Rome. 2021. (31 August 2024) https://doi.org/10.4060/cb3434enhttps://openknowledge.fao.org/handle/20.500.14283/cb3434en

5. Рекомендации по потреблению насыщенных жирных кислот и транс-изомеров жирных кислот взрослыми и детьми: краткое изложение руководства ВОЗ. Всемирная организация здравоохранения.Всемирная организация здравоохранения. (2023). https://iris.who.int/handle/10665/375037. License: CC BY-NC-SA 3.0 IGO ISBN: 9789240083684

6. Guideline: Sugars intake for adults and children. Geneva: World Health Organization; 2015. https: Guideline: sugars intake for adults and children (who.int) https://www.who.int/publications/i/item/9789241549028

7. Guideline: Sodium intake for adults and children. Geneva: World Health Organization; 2012. https: Guideline: sodium intake for adults and children (who.int) https://www.who.int/publications/i/item/9789241504836

8. Diet, nutrition and the prevention of chronic diseases: report of a Joint WHO/FAO expert consultation. Geneva: World Health Organization; 2003. https://apps.who.int/iris/handle/10665/42665

9. Бойцов С.А., Погосова Н.В., Аншелес А.А. и соавт. Кардиоваскулярная профилактика 2022. Российские национальные рекомендации. Российский кардиологический журнал. 2023;28(5):5452. https://doi.org/10.15829/1560-4071-2023-5452

10. Рекомендации по потреблению углеводов взрослыми и детьми: краткое изложение руководства ВОЗ [Carbohydrate intake for adults and children: WHO guideline summary]. Женева: Всемирная организация здравоохранения; 2023 r. Лицензия: CC BY-NC-SA 3.0 IGO ISBN: 924008343X, 9789240083431

11. European Heart Network. Transforming European food and drink policies for cardiovascular health. 1093:transforming-european-foodand-drinks-policies-forcardiovascular-health.html (31 August 2024). http://www.ehnheart.org/publications-andpapers/publications/

12. Алкоголь и онкологические заболевания в Европейском регионе ВОЗ. Призыв к более активной профилактике. Копенгаген: Европейское региональное бюро ВОЗ; 2020. https://iris.who.int/bitstream/handle/10665/336625/WHO-EURO-2020-1435-41185-56124-rus.pdf?sequence=1 (31 August 2024).

13. Marx N, Federici M, Schütt K et al. ESC Scientific Document Group. 2023 ESC Guidelines for the management of cardiovascular disease in patients with diabetes. Eur Heart J. 2023;44(39):4043-4140. https://doi.org/10.1093/eurheartj/ehad192

14. Badimon L, Chagas P, Chiva-Blanch G. Diet and Cardiovascular Disease: Effects of Foods and Nutrients in Classical and Emerging Cardiovascular Risk Factors. Curr Med Chem. 2019;26(19):3639-3651. https://doi.org/10.2174/0929867324666170428103206

15. McEvoy JW, McCarthy CP, Bruno RM et al. ESC Scientific Document Group. 2024 ESC Guidelines for the management of elevated blood pressure and hypertension. Eur Heart J. 2024:ehae178. https://doi.org/10.1093/eurheartj/ehae178

16. Eilat-Adar S, Sinai T, Yosefy C et al. Nutritional recommendations for cardiovascular disease prevention. Nutrients. 2013;5(9):3646-83. https://doi.org/10.3390/nu5093646

17. Sofi F, Abbate R, Gensini GF et al. Accruing evidence on benefits of adherence to the Mediterranean diet on health: an updated systematic review and meta-analysis. Am J Clin Nutr. 2010;92(5):1189-96. https://doi.org/10.3945/ajcn.2010.29673

18. Estruch R, Ros E, Salas-Salvadó J et al. Primary Prevention of Cardiovascular Disease with a Mediterranean Diet Supplemented with Extra-Virgin Olive Oil or Nuts. N Engl J Med. 2018;378(25):e34. https://doi.org/10.1056/NEJMoa1800389

19. Delgado-Lista J, Alcala-Diaz JF, Torres-Peña JD et al. Longterm secondary prevention of cardiovascular disease with a Mediterranean diet and a low-fat diet (CORDIOPREV): a randomised controlled trial. Lancet 2022;399:1876–1885. https://doi.org/10.1016/S0140-6736(22)00122-2

20. Mensink RP. Effects of saturated fatty acids on serum lipids and lipoproteins: a systematic review and regression analysis. https://iris.who.int/handle/10665/246104 (31 August 2024).

21. Guasch-Ferré M, Satija A, Blondin SA et al. Meta-Analysis of Randomized Controlled Trials of Red Meat Consumption in Comparison With Various Comparison Diets on Cardiovascular Risk Factors. Circulation. 2019;139(15):1828-1845. https://doi.org/10.1161/CIRCULATIONAHA.118.035225

22. Sacks FM, Lichtenstein AH, Wu JHY et al. Dietary Fats and Cardiovascular Disease: A Presidential Advisory From the American Heart Association Circulation. 2017;136(3):e1-e23. https://doi.org/10.1161/CIR.0000000000000510

23. He FJ, Tan M, Ma Y, MacGregor GA. Salt Reduction to Prevent Hypertension and Cardiovascular Disease: JACC State-of-the-Art Review. J Am Coll Cardiol. 2020;75(6):632-647. https://doi.org/10.1016/j.jacc.2019.11.055

24. Threapleton DE, Greenwood DC, Evans CE et al. Dietary fibre intake and risk of cardiovascular disease: systematic review and meta-analysis. BMJ. 2013;347:f6879. https://doi.org/10.1136/bmj.f6879

25. Zurbau A, Au-Yeung F, Mejia SB et al. Relation of Different Fruit and Vegetable Sources With Incident Cardiovascular Outcomes: A Systematic Review and Meta-Analysis of Prospective Cohort Studies. J Am Heart Assoc. 2020;9(19):e017728. https://doi.org/10.1161/JAHA.120.017728

26. Aune D, Keum N, Giovannucci E et al. Whole grain consumption and risk of cardiovascular disease, cancer, and all cause and cause specific mortality: systematic review and dose-response meta-analysis of prospective studies. BMJ. 2016;353:i2716. https://doi.org/10.1136/bmj.i2716

27. Reynolds A, Mann J, Cummings J et al. Carbohydrate quality and human health: a series of systematic reviews and meta-analyses. Lancet. 2019;393(10170):434-445. https://doi.org/10.1016/S0140-6736(18)31809-9

28. Aune D, Giovannucci E, Boffetta P et al. Fruit and vegetable intake and the risk of cardiovascular disease, total cancer and all-cause mortality-a systematic review and dose-response meta-analysis of prospective studies. Int J Epidemiol. 2017;46(3):1029-1056. https://doi.org/10.1093/ije/dyw319

29. Zeraatkar D, Johnston BC, Bartoszko J et al. Effect of Lower Versus Higher Red Meat Intake on Cardiometabolic and Cancer Outcomes: A Systematic Review of Randomized Trials. Ann Intern Med. 2019;171(10):721-731. https://doi.org/10.7326/M19-0622

30. Zhong VW, Van Horn L, Greenland P et al. Associations of Processed Meat, Unprocessed Red Meat, Poultry, or Fish Intake With Incident Cardiovascular Disease and All-Cause Mortality. JAMA Intern Med. 2020;180(4):503-512. https://doi.org/10.1001/jamainternmed.2019.6969

31. Zheng J, Huang T, Yu Y et al. Fish consumption and CHD mortality: an updated meta-analysis of seventeen cohort studies. Public Health Nutr. 2012;15(4):725-37. https://doi.org/10.1017/S1368980011002254

32. Mullee A, Romaguera D, Pearson-Stuttard J et al. Association Between Soft Drink Consumption and Mortality in 10 European Countries. JAMA Intern Med. 2019;179(11):1479-1490. https://doi.org/10.1001/jamainternmed.2019.2478

33. Wood AM, Kaptoge S, Butterworth AS et al. Emerging Risk Factors Collaboration/EPIC-CVD/UK Biobank Alcohol Study Group. Risk thresholds for alcohol consumption: combined analysis of individual-participant data for 599 912 current drinkers in 83 prospective studies. Lancet. 2018;391(10129):1513-1523. https://doi.org/10.1016/S0140-6736(18)30134-X

34. Millwood IY, Walters RG, Mei XW et al. China Kadoorie Biobank Collaborative Group. Conventional and genetic evidence on alcohol and vascular disease aetiology: a prospective study of 500 000 men and women in China. Lancet. 2019;393(10183):1831-1842. https://doi.org/10.1016/S0140-6736(18)31772-0

35. Holmes MV, Dale CE, Zuccolo L et al. InterAct Consortium. Association between alcohol and cardiovascular disease: Mendelian randomisation analysis based on individual participant data. BMJ. 2014;349:g4164. https://doi.org/10.1136/bmj.g4164

36. Hooper L, Martin N, Jimoh OF et al. Reduction in saturated fat intake for cardiovascular disease. Cochrane Database Syst Rev. 2020;5(5):CD011737. https://doi.org/10.1002/14651858.CD011737.pub2

37. Reynolds AN, Hodson L, De Souza R et al. Saturated fat and transfat intakes and their replacement with other macronutrients: a systematic review and meta-analysis of prospective observational studies. Geneva: World Health Organization; 2022. https://apps.who.int/iris/handle/10665/366301 (31 August 2024)

38. Globalization, diets and noncommunicable diseases. Geneva, World Health Organization, 2002 http://whqlibdoc.who.int/publications/9241590416.pdf (31 August 2024)

39. Reynolds AN, Hodson L, De Souza R et al. Saturated fat and transfat intakes and their replacement with other macronutrients: a systematic review and meta-analysis of prospective observational studies. Geneva: World Health Organization; 2022 (https://apps.who.int/iris/handle/10665/366301) (31 August 2024)

40. Brouwer I. Effect of trans-fatty acid intake on blood lipids and lipoproteins: a systematic review and meta-regression analysis. Geneva: World Health Organization; 2016 https://apps.who.int/iris/handle/10665/246109 (31 August 2024)

41. GBD 2017 Diet Collaborators. Health effects of dietary risks in 195 countries, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2019;393:1958-72. https://doi.org/10.1016/S0140-6736(19)30041-8

42. Официальный сайт Федеральной службы государственной статистики. Итоги «Выборочного наблюдения рациона питания населения». https://rosstat.gov.ru/itog_inspect

43. Карамнова Н.С., Максимов С.А., Капустина А.В. и соавт. Избыточное потребление соли в российской популяции: распространенность, ассоциации с социально-демографическими показателями, факторами риска и заболеваниями, региональные аспекты. Результаты эпидемиологических исследований ЭССЕ-РФ и ЭГИДА-Москва. Кардиоваскулярная терапия и профилактика. 2023;22(12):3827. EDN KIGJNL. https://doi.org/10.15829/1728-8800-2023-3827

44. Карамнова Н. С., Капустина А. В., Куценко В. А. и соавторы. Привычки питания и риск смерти от всех причин во взрослой популяции. Результаты 6-летнего проспективного наблюдения за когортой исследования ЭССЕ-РФ. Кардиоваскулярная терапия и профилактика. 2024;23(9):4113. EDN CHSTLZ. https://doi.org/10.15829/1728-8800-2024-4113

45. O’Donnell M, Mente A, Rangarajan S et al. Urinary sodium and potassium excretion, mortality, and cardiovascular events. N Engl J Med 2014; 371:612–23. https://doi.org/10.1056/NEJMoa1311889

46. Mente A, O’Donnell M, Rangarajan S et al. Urinary sodium excretion, blood pressure, cardiovascular disease, and mortality: a community-level prospective epidemiological cohort study. Lancet 2018;392: 496–506. https://doi.org/10.1016/s0140-6736(18)31376-x

47. Saudan P, Brown MA, Buddle ML et al. Does gestational hypertension become pre-eclampsia? Br J Obstet Gynaecol 1998;105:1177-84. https://doi.org/10.1111/j.1471-0528.1998.tb09971.x

48. Aburto NJ, Hanson S, Gutierrez H et al. Effect of increased potassium intake on cardiovascular risk factors and disease: systematic review and meta-analyses. BMJ. 2013 Apr 3;346:f1378. https://doi.org/10.1136/bmj.f1378

49. Guideline: Potassium intake for adults and children. Geneva: World Health Organization; 2012. https://www.who.int/publications/i/item/9789241504829

50. Filippini T, Naska A, Kasdagli MI et al. Potassium intake and blood pressure: a dose-response meta-analysis of randomized controlled trials. J Am Heart Assoc 2020;9:e015719. https://doi.org/10.1161/jaha.119.015719

51. Тутельян В.А. Химический состав и калорийность российских продуктов питания: справочник. Москва: ДеЛи плюс, 2012. 284 с. ISBN: 978-5-905170-20.

52. Tasevska N, Park Y, Jiao L et al. Sugars and risk of mortality in the NIH-AARP Diet and Health Study. Am J Clin Nutr. 2014 May;99(5):1077-88. https://doi.org/10.3945/ajcn.113.069369

53. Te Morenga LA, Howatson AJ, Jones RM et al. Dietary sugars and cardiometabolic risk: systematic review and meta-analyses of randomized controlled trials of the effects on blood pressure and lipids. Am J Clin Nutr. 2014;100(1):65-79. https://doi.org/10.3945/ajcn.113.081521

54. Jayalath VH, de Souza RJ, Ha V et al. Sugar-sweetened beverage consumption and incident hypertension: a systematic review and meta-analysis of prospective cohorts. Am J Clin Nutr. 2015;102(4):914-21. https://doi.org/10.3945/ajcn.115.107243

55. Yin J, Zhu Y, Malik V et al. Intake of Sugar-Sweetened and Low-Calorie Sweetened Beverages and Risk of Cardiovascular Disease: A Meta-Analysis and Systematic Review. Adv Nutr. 2021;12(1):89-101. https://doi.org/10.1093/advances/nmaa084

56. Xi Bo et al. “Sugar-sweetened beverages and risk of hypertension and CVD: a dose-response meta-analysis.” The British journal of nutrition 2015,113;5: 709-17. https://doi.org/10.1017/S0007114514004383

57. Yang Q, Zhang Z, Gregg EW et al. Added sugar intake and cardiovascular diseases mortality among US adults. JAMA Intern Med. 2014;174(4):516-24. https://doi.org/10.1001/jamainternmed.2013.13563

58. Применение не содержащих сахар подсластителей: краткое изложение руководства ВОЗ [Use of non-sugar sweeteners: WHO guideline summary]. Женева: Всемирная организация здравоохранения; 2023 r. Лицензия: CC BY-NC-SA 3.0 IGO. https://www.who.int/ru/publications/b/70891 (31 August 2024)

59. Magnuson BA, Carakostas MC, Moore NH et al. Biological fate of low-calorie sweeteners. Nutr Rev. 2016;74(11):670-689. https://doi.org/10.1093/nutrit/nuw032

60. Toews I, Lohner S, Küllenberg de Gaudry D et al. Association between intake of non-sugar sweeteners and health outcomes: systematic review and meta-analyses of randomised and nonrandomised controlled trials and observational studies. BMJ. 2019;364:k4718. https://doi.org/10.1136/bmj.k4718

61. Rios-Leyvraz M, Montez J. Health effects of the use of non-sugar sweeteners: a systematic review and meta-analysis. Geneva: World Health Organization; 2022. Licence: CC BY-NC-SA 3.0 IGO. https://iris.who.int/handle/10665/353064 (31 August 2024)

62. Iqbal R, Dehghan M, Mente A et al. Associations of unprocessed and processed meat intake with mortality and cardiovascular disease in 21 countries [Prospective Urban Rural Epidemiology (PURE) Study]: a prospective cohort study. Am J Clin Nutr. 2021;114(3):1049-1058. https://doi.org/10.1093/ajcn/nqaa448

63. Chowdhury R, Kunutsor S, Vitezova A et al. Vitamin D and risk of cause specific death: systematic review and meta-analysis of observational cohort and randomised intervention studies. BMJ. 2014;348:g1903. https://doi.org/10.1136/bmj.g1903

64. Zhao LG, Sun JW, Yang Y et al. Fish consumption and all-cause mortality: a meta-analysis of cohort studies. Eur J Clin Nutr. 2016;70(2):155-61. https://doi.org/10.1038/ejcn.2015.72

65. Luo C, Zhang Y, Ding Y et al. Nut consumption and risk of type 2 diabetes, cardiovascular disease, and all-cause mortality: a systematic review and meta-analysis. Am J Clin Nutr. 2014;100(1):256-69. https://doi.org/10.3945/ajcn.113.076109

66. Arnett D, Blumenthal R, Albert M. et al. 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. JACC. 2019 Sep, 74 (10) e177–232. https://doi.org/10.1016/j.jacc.2019.03.010

67. Willett WC, Sacks F, Trichopoulou A et al. Mediterranean diet pyramid: A cultural model for healthy eating. American Journal of Clinical Nutrition. 1995; 61(6): 1402–6. https://doi.org/10.1093/ajcn/61.6.1402S

68. Soltani S, Jayedi A, Shab-Bidar S et al. Adherence to the Mediterranean Diet in Relation to All-Cause Mortality: A Systematic Review and Dose-Response Meta-Analysis of Prospective Cohort Studies. Adv Nutr. 2019;10(6):1029-1039. https://doi.org/10.1093/advances/nmz041

69. Dinu M, Pagliai G, Casini A et al. Mediterranean diet and multiple health outcomes: an umbrella review of meta-analyses of observational studies and randomised trials. Eur J Clin Nutr. 2018;72(1):30-43. https://doi.org/10.1038/ejcn.2017.58

70. Mithril C, Dragsted LO, Meyer C et al. Dietary composition and nutrient content of the New Nordic Diet. Public Health Nutr. 2013;16(5):777-85. https://doi.org/10.1017/S1368980012004521

71. Kanerva N, Kaartinen NE, Schwab U et al. The Baltic Sea Diet Score: a tool for assessing healthy eating in Nordic countries. Public Health Nutr. 2014;17(8):1697-705. https://doi.org/10.1017/S1368980013002395

72. Jalilpiran Y, Jayedi A, Djafarian K et al. The Nordic diet and the risk of non-communicable chronic disease and mortality: a systematic review and dose-response meta-analysis of prospective cohort studies. CritRevFoodSciNutr. 2022;62(11):3124-3136. https://doi.org/10.1080/10408398.2020.1863906

73. Massara P, Zurbau A, Glenn AJ et al. Nordic dietary patterns and cardiometabolic outcomes: a systematic review and metaanalysis of prospective cohort studies and randomised controlled trials. Diabetologia. 2022;2011–2031. https://doi.org/10.1007/s00125-022-05760-z

74. Ramezani-Jolfaie Nahid et al. The effect of healthy Nordic diet on cardio-metabolic markers: a systematic review and meta-analysis of randomized controlled clinical trials. European Journal of Nutrition. 2018;1-16. https://doi.org/10.1007/s00394-018-1804-0

75. Appel LJ, Moore TJ, Obarzanek E et al. A clinical trial of the effects of dietary patterns on blood pressure. DASH Collaborative Research Group. N Engl J Med. 1997;336(16):1117-24. https://doi.org/10.1056/NEJM199704173361601

76. Ge L, Sadeghirad B, Ball GDC et al. Comparison of dietary macronutrient patterns of 14 popular named dietary programmes for weight and cardiovascular risk factor reduction in adults: systematic review and network meta-analysis of randomised trials. BMJ. 2020;369:m696. https://doi.org/:10.1136/bmj.m696

77. Sacks FM, Svetkey LP, Vollmer WM et al. Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet. N Engl J Med. 2001;344(1):3-10. https://doi.org/10.1056/NEJM200101043440101

78. Saneei P, Salehi-Abargouei A, Esmaillzadeh A et al. Influence of Dietary Approaches to Stop Hypertension (DASH) diet on blood pressure: a systematic review and meta-analysis on randomized controlled trials. Nutr Metab Cardiovasc Dis.2014;24(12):1253-61. https://doi.org/10.1016/j.numecd.2014.06.008

79. Gay HC, Rao SG, Vaccarino V et al. Effects of different dietary interventions on blood pressure: systematic review and metaanalysis of randomized controlled trials. Hypertension 2016;67:733–9. https://doi.org/10.1161/hypertensionaha.115.06853

80. Siervo M, Lara J, Chowdhury S et al. Effects of the Dietary Approach to Stop Hypertension (DASH) diet on cardiovascular risk factors: a systematic review and meta-analysis. Br J Nutr. 2015;113(1):1-15. https://doi.org/10.1017/S0007114514003341

81. Soltani S, Arablou T, Jayedi A et al. Adherence to the dietary approaches to stop hypertension (DASH) diet in relation to allcause and cause-specific mortality: a systematic review and dose-response meta-analysis of prospective cohort studies. Nutr J. 2020;19(1):37. https://doi.org/10.1186/s12937-020-00554-8

82. Morris MC, Tangney CC, Wang Y et al. MIND diet slows cognitive decline with aging. Alzheimers Dement. 2015;11(9):1015-22. https://doi.org/10.1016/j.jalz.2015.04.011

83. Dhana K, James BD, Agarwal P et al. MIND Diet, Common Brain Pathologies, and Cognition in Community-Dwelling Older Adults. J Alzheimers Dis. 2021;83(2):683-692. https://doi.org/10.3233/JAD-210107

84. Cherian L, Wang Y, Fakuda K et al. Mediterranean-Dash Intervention for Neurodegenerative Delay (MIND) Diet Slows Cognitive Decline After Stroke. J Prev Alzheimers Dis. 2019;6(4):267-273. https://doi.org/10.14283/jpad.2019.28

85. Hosking DE, Eramudugolla R, Cherbuin N et al. MIND not Mediterranean diet related to 12-year incidence of cognitive impairment in an Australian longitudinal cohort study. Alzheimers Dement. 2019 Apr;15(4):581-589. https://doi.org/10.1016/j.jalz.2018.12.011

86. Melo van Lent D, O'Donnell A, Beiser AS et al. Mind Diet Adherence and Cognitive Performance in the Framingham Heart Study. J Alzheimers Dis. 2021;82(2):827-839. https://doi.org/10.3233/JAD-201238

87. Chen H, Dhana K, Huang Y et al. Association of the Mediterranean Dietary Approaches to Stop Hypertension Intervention for Neurodegenerative Delay (MIND) Diet With the Risk of Dementia. JAMA Psychiatry. 2023;80(6):630-638. https://doi.org/10.1001/jamapsychiatry.2023.0800

88. Barnes LL, Dhana K, Liu X et al. Trial of the MIND Diet for Prevention of Cognitive Decline in Older Persons. N Engl J Med. 2023;389(7):602-611. https://doi.org/10.1056/NEJMoa2302368

89. Song Y, Chang Z, Cui K et al. The value of the MIND diet in the primary and secondary prevention of hypertension: A cross-sectional and longitudinal cohort study from NHANES analysis. Front Nutr. 2023;10:1129667. https://doi.org/10.3389/fnut.2023.1129667

90. Akbar Z, Fituri S, Ouagueni A et al. Associations of the MIND Diet with Cardiometabolic Diseases and Their Risk Factors: ASystematic Review. Diabetes Metab Syndr Obes. 2023;16:3353-3371. https://doi.org/10.2147/DMSO.S427412

91. Arjmand G, Abbas-Zadeh M, Fardaei M et al. The Effect of Short-term Mediterranean-DASH Intervention for Neurodegenerative Delay (MIND) diet on hunger hormones, anthropometric parameters, and brain structures in middle-aged overweight and obese women: a randomized controlled trial. Iran J Med Sci. 2022;47(5):422-432. https://doi.org/10.30476/IJMS.2021.90829.2180

92. Elsayed MM, Rabiee A, El Refaye GE et al. Aerobic exercise with Mediterranean-DASH intervention for neurodegenerative delay diet promotes brain cells’ longevity despite sex hormone deficiency in postmenopausal women: a randomized controlled trial. Oxid Med Cell Longev. 2022;2022:4146742. https://doi.org/10.1155/2022/4146742

93. The Diabetes and Nutrition Study Group (DNSG) of the European Association for the Study of Diabetes (EASD). Evidence-based European recommendations for the dietary management of diabetes. Diabetologia 66, 965-985 (2023). https://doi.org/10.1007/s00125-023-05894-8

94. Chiavaroli L, Nishi SK, Khan TA et al. Portfolio Dietary Pattern and Cardiovascular Disease: A Systematic Review and Meta-analysis of Controlled Trials. Prog Cardiovasc Dis. 2018;61(1):43-53. https://doi.org/10.1016/j.pcad.2018.05.004

95. Glenn AJ, Hernández-Alonso P, Kendall CW et al. Longitudinal changes in adherence to the portfolio and DASH dietary patterns and cardiometabolic risk factors in the PREDIMED-Plus study. Clin Nutr.2021;40(5):2825-2836. https://doi.org/10.1016/j.clnu.2021.03.016

96. Glenn AJ, Li J, Lo K et al. The Portfolio Diet and Incident Type 2 Diabetes: Findings From the Women's Health Initiative Prospective Cohort Study. Diabetes Care. 2023;46(1):28-37. https://doi.org/10.2337/dc22-1029

97. Lo K, Glenn AJ, Yeung S et al. Prospective association of the Portfolio diet with all-cause and cause-specific mortality risk in the Mr. OS and Ms. OS Study. Nutrients.2021;13(12):4360. https://doi.org/10.3390/nu13124360

98. Plant-based diets and their impact on health, sustainability and the environment: a review of the evidence: WHO European Office for the Prevention and Control of Noncommunicable Diseases. Copenhagen: WHO Regional Office for Europe; 2021. Licence: CC BY-NC-SA 3.0 IGO.

99. Tong TYN, Appleby PN, Bradbury KE et al. Risks of ischaemic heart disease and stroke in meat eaters, fish eaters, and vegetarians over 18 years of follow-up: results from the prospective EPICOxford study. BMJ. 2019;366:l4897. https://doi.org/10.1136/bmj.l4897

100. Kaiser A, van Daalen KR, Tayyil A et al. A systematic review of the association between vegan diets and risk of cardiovascular disease. J Nutr. 2021;151(6):1539-52. https://doi.org/10.1093/jn/nxab037

101. Jabri A, Kumar A, Verghese E et al. Meta-analysis of effect of vegetarian diet on ischemic heart disease and all-cause mortality. Am J Prev Cardiol.2021;7:100182. https://doi.org/10.1016/j.ajpc.2021.100182

102. Benatar JR, Stewart RAH Cardiometabolic risk factors in vegans; A meta-analysis of observational studies. PLoS ONE. 2018;13:e0209086. https://doi.org/10.1371/journal.pone.0209086

103. Rizzo NS, Sabaté J, Jaceldo-Siegl K et al. Vegetarian dietary patterns are associated with a lower risk of metabolic syndrome: the Аdventist health study 2. Diabetes Care. 2011;34(5):1225-1227. https://doi.org/10.2337/dc10-1221

104. Matsumoto S, Beeson WL, Shavlik DJ et al. Association between vegetarian diets and cardiovascular risk factors in non-Hispanic white participants of the Adventist Health Study-2. Journal of nutritional science. 2019;8:e6. https://doi.org/10.1017/jns.2019.1

105. Wang T, Kroeger CV, Cassidy S et al. Vegetarian Dietary Patterns and Cardiometabolic Risk in People With or at High Risk of Cardiovascular Disease A Systematic Review and Metaanalysis JAMA Network Open. 2023;6(7):e2325658. https://doi.org/10.1001/jamanetworkopen.2023.25658

106. Wang F, Zheng J, Yang B et al. Effects of Vegetarian Diets on Blood Lipids: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Journal of the American Heart Association. 2015;4(10):e002408. https://doi.org/10.1161/JAHA.115.002408

107. Yokoyama Y, Levin SM, Barnard ND. Association between plantbased diets and plasma lipids: a systematic review and metaanalysis. Nutr Rev. 2017;75(9):683-698. https://doi.org/10.1093/nutrit/nux030

108. Ocagli H, Berti G, Rango D et al. Association of Vegetarian and Vegan Diets with Cardiovascular Health: An Umbrella Review of Meta-Analysis of Observational Studies and Randomized Trials. Nutrients. 2023;15:4103. https://doi.org/10.3390/nu15194103

109. Perez-Cornago A, Crowe FL, Appleby PN et al. Plant foods, dietary fibre and risk of ischaemic heart disease in the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort. Int J Epidemiol. 2021;50(1):212-22. https://doi.org/10.1093/ije/dyaa155

110. Tong TYN, Appleby PN, Key TJ et al. The associations of major foods and fibre with risks of ischaemic and haemorrhagic stroke: a prospective study of 418 329 participants in the EPIC cohort across nine European countries. Eur Heart J. 2020;41(28):2632-40. https://doi.org/10.1093/eurheartj/ehaa007

111. Jardine MA, Kahleova H, Levin SM et al. Perspective: plant-based eating pattern for type 2 diabetes prevention and treatment: efficacy, mechanisms, and practical con¬siderations. Adv Nutr. 2021:nmab063. https://doi.org/10.1093/advances/nmab063

112. Qian F, Liu G, Hu FB et al. Association between plant-based dietary patterns and risk of type 2 diabetes: a systematic review and meta-analysis. JAMA Intern Med. 2019;179(10):1335-44. https://doi.org/10.1001/jamainternmed.2019.2195

113. Papier K, Appleby PN, Fensom GK et al. Vegetarian diets and risk of hospitalisation or death with diabetes in British adults: results from the EPIC-Oxford study. Nutr Diabetes. 2019;9(1):7. https://doi.org/10.1038/s41387-019-0074-0

114. Segovia-Siapco G, Sabaté J. Health and sustainability outcomes of vegetarian dietary patterns: a revisit of the EPIC-Oxford and the Adventist Health Study-2 cohorts. Eur J Clin Nutr. 2019;72(Suppl 1):60-70. https://doi.org/10.1038/s41430-018-0310-z

115. Key TJ, Appleby PN, Crowe FL et al. Cancer in British vegetarians: updated analyses of 4998 incident cancers in a cohort of 32,491 meat eaters, 8612 fish eaters, 18,298 vegetarians, and 2246 vegans. Am J Clin Nutr. 2014;100 Suppl 1(1):378S-85S. https://doi.org/10.3945/ajcn.113.071266

116. Watling CZ, Schmidt JA, Dunneram Y et al. Risk of cancer in regular and low meat-eaters, fish-eaters, and vegetarians: a prospective analysis of UK Biobank participants. BMC Med. 2022;20(1):73. https://doi.org/10.1186/s12916-022-02256-w

117. Orlich MJ, Singh PN, Sabaté J et al. Vegetarian dietary patterns and mortality in Adventist Health Study 2. JAMA Intern Med. 2013;173(13):1230-1238. https://doi.org/10.1001/jamainternmed.2013.6473

118. Appleby PN, Crowe FL, Bradbury KE et al. Mortality in vegetarians and comparable nonvegetarians in the United Kingdom. Am J Clin Nutr. 2016;103(1):218-230. https://doi.org/10.3945/ajcn.115.119461

119. Petermann-Rocha F, Parra-Soto S, Gray S et al. Vegetarians, fish, poultry, and meat-eaters: who has higher risk of cardiovascular disease incidence and mortality? A prospective study from UK Biobank. Eur Heart J. 2021;42(12):1136-1143. https://doi.org/10.1093/eurheartj/ehaa939

120. Bakaloudi DR, Halloran A, Rippin HL et al. Intake and adequacy of the vegan diet: a systematic review of the evidence. Clin Nutr. 2021;40(5):3503-21. https://doi.org/10.1016/j.clnu.2020.11.035

121. Melina V, Craig W, Levin S Position of the Academy of Nutrition and Dietetics: vegetarian diets. J Acad Nutr Diet. 2016;116(12):1970-80. https://doi.org/10.1016/j.jand.2016.09.025

122. Willett W, Rockstrom J, Loken B et al. Food in the Anthropocene: the EAT-Lancet Commission on healthy diets from sustainable food systems. Lancet 2019;393:447-492. https://doi.org/10.1016/S0140-6736(18)31788-4

123. Драпкина О.М., Карамнова Н.С., Максимов С.А. и соавт. Вегетарианские рационы: распространенность в российской популяции, региональные акценты и ассоциации с факторами риска сердечно-сосудистых заболеваний. Результаты эпидемиологических исследований ЭССЕ-РФ, ЭССЕ-РФ2 и ЭССЕ-РФ3. Кардиоваскулярная терапия и профилактика. 2023;22(8S):3794. https://doi.org/10.15829/1728-8800-2023-3794

124. Popp CJ, Hu L, Kharmats AY et al. Effect of a Personalized Diet to Reduce Postprandial Glycemic Response vs a Lowfat Diet on Weight Loss in Adults With Abnormal Glucose Metabolism and Obesity: A Randomized Clinical Trial. JAMA Netw Open. 2022;5(9):e2233760. https://doi.org/10.1001/jamanetworkopen.2022.33760

125. Shai I, Schwarzfuchs D, Henkin Y et al; Dietary Intervention Randomized Controlled Trial (DIRECT) Group. Weight loss with a low-carbohydrate, Mediterranean, or low-fat diet. N Engl J Med. 2008 Jul 17;359(3):229-41. https://doi.org/10.1056/NEJMoa0708681

126. Tobias DK, Chen M, Manson JE et al. Effect of low-fat diet interventions versus other diet interventions on long-term weight change in adults: a systematic review and meta-analysis. Lancet DiabetesEndocrinol. 2015;3(12):968-79. https://doi.org/10.1016/S2213-8587(15)00367-8

127. Gepner Y, Shelef I, Komy O et al. The beneficial effects of Mediterranean diet over low-fat diet may be mediated by decreasing hepatic fat content. J Hepatol. 2019;71(2):379-388. https://doi.org/10.1016/j.jhep.2019.04.013

128. Montalescot G, SechtemU, Achenbach S et al. 2013 ESC guidelines on the management of stable coronary artery disease: the Task Force on the management of stable Coronary artery disease of European Society of Cardiology. Eur Heart J. 2013;34:2949-3003. https://doi.org/10.1093/eurheartj/eht296

129. Clinical practice guidelines for Stable coronary artery disease. Russian Journal of Cardiology. 2020;25(11):4076. (In Russ.) Стабильная ишемическая болезнь сердца. Клинические рекомендации2020. Российский кардиологический журнал.2020;25(11):4076. https://doi.org/10.15829/1560-4071-2020-4076.2020

130. Швабская О.Б., Карамнова Н.С., Измайлова О.В. Здоровое питание: новые рационы для индивидуального использования. Рациональная Фармакотерапия в Кардиологии 2020;16(6):958-965. https://doi.org/10.20996/1819-6446-2020-12-12

131. Dong TA, Sandesara PB, Dhindsa DS et al. Intermittent Fasting: A Heart Healthy Dietary Pattern? Am J Med. 2020;S0002-9343(20)30335-1. https://doi.org/10.1016/j.amjmed.2020.03.030

132. Lindeberg S, Jönsson T, Granfeldt Y et al. Palaeolithic diet improves glucose tolerance more than a Mediterranean-like diet in individuals with ischaemic heart disease. Diabetologia. 2007;50(9):1795-807. https://doi.org/10.1007/s00125-007-0716-y

133. Seidelmann SB, Claggett B, Cheng S et al. Dietary carbohydrate intake and mortality: a prospective cohort study and metaanalysis. Lancet Public Health. 2018;3(9):e419-e428. https://doi.org/10.1016/S2468-2667(18)30135-X

134. Trichopoulou A, Psaltopoulou T, Orfanos P et al. Lowcarbohydrate-high-protein diet and long-term survival in a general population cohort. Eur J Clin Nutr. 2007;61(5):575-81. https://doi.org/10.1038/sj.ejcn.1602557

135. Whelton PK, Carey RM, Aronow WS, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Hypertension. 2018;71(6):e13-e115. https://doi.org/10.1161/HYP.0000000000000065

136. Mancia G, Kreutz R, Brunström M, et al. 2023 ESH Guidelines for the management of arterial hypertension The Task Force for the management of arterial hypertension of the European Society of Hypertension: Endorsed by the International Society of Hypertension (ISH) and the European Renal Association (ERA). J Hypertens. 2023;41(12):1874-2071. https://doi.org/10.1097/HJH.0000000000003480

137. Аксенова, А.В., О.А. Сивакова, Н.В. Блинова и соавт. Консенсус экспертов Российского медицинского общества по артериальной гипертонии по диагностике и лечению резистентной артериальной гипертонии. Терапевтический архив 2021;93(9):1018-1029. https://doi.org/10.26442/00403660.2021.09.201007

138. Pazoki R, Dehghan A, Evangelou E, et al. Genetic Predisposition to High Blood Pressure and Lifestyle Factors: Associations With Midlife Blood Pressure Levels and Cardiovascular Events. Circulation 2018; 137:653–661. https://doi.org/10.1161/circulationaha.117.030898

139. Pescatello LS, Wu Y, Gao S, et al. Do the combined blood pressure effects of exercise and antihypertensive medications add up to the sum of their parts? A systematic meta-review. BMJ Open Sport Exerc Med 2021; 7:e000895. https://doi.org/10.1136/bmjsem-2020-000895

140. Goldie FC, BradyA JB. New National Institute for Health and Care Excellence guidance for hypertension: a review and comparison with the US and European guidelines. Heart. 2024;110(6):399-401. https://doi.org/10.1136/heartjnl-2022-322118

141. Blumenthal JA, Babyak MA, Sherwood A, et al. Effects of the dietary approaches to stop hypertension diet alone and in combination with exercise and caloric restriction on insulin sensitivity and lipids. Hypertension (Dallas, Tex: 1979) 2010; 55:1199-1205. https://doi.org/10.1161/hypertensionaha.109.149153

142. Filippini T, Malavolti M, Whelton PK, et al. Blood Pressure Effects of Sodium Reduction: Dose-Response Meta-Analysis of Experimental Studies. Circulation 2021; 143:1542–1567. https://doi.org/10.1161/circulationaha.120.050371

143. Filippini T, Naska A, Kasdagli MI, et al. Potassium Intake and Blood Pressure: A Dose-Response Meta-Analysis of Randomized Controlled Trials. J Am Heart Assoc 2020; 9:e015719. https://doi.org/10.1161/jaha.119.015719

144. Noone C, Leahy J, Morrissey EC, et al. Comparative efficacy of exercise and anti-hypertensive pharmacological interventions in reducing blood pressure in people with hypertension: A network meta-analysis. Eur J PrevCardiol 2020; 27:247–255. https://doi.org/10.1177/2047487319879786

145. Zhong L, Chen W, Wang T, et al. Alcohol and Health Outcomes: An Umbrella Review of Meta-Analyses Base on Prospective Cohort Studies. Front Public Health 2022; 10:859947. https://doi.org/10.3389/fpubh.2022.859947

146. Хачатрян Н.Т., Жернакова Ю.В., Блинова Н.В., Чазова И.Е. Изучение различных диетических вмешательств у пациентов с артериальной гипертонией и метаболическим синдромом. Системные гипертензии. 2024;21(1):29-35. https://doi.org/10.38109/2075-082X-2024-1-29-35

147. Nguyen B, Bauman A, Ding D. Association between lifestyle risk factors and incident hypertension among middle-aged and older Australians. Prev Med 2019; 118:73–80. https://doi.org/10.1016/j.ypmed.2018.10.007

148. Fu J, Liu Y, Zhang L, et al. Nonpharmacologic Interventions for Reducing Blood Pressure in Adults With Prehypertension to Established Hypertension. J Am Heart Assoc 2020; 9:e016804. https://doi.org/10.1161/jaha.120.016804

149. Аксенова А.В., Ощепкова Е.В., Горбунова Е.В., и соавт. Контролируемая и неконтролируемая артериальная гипертония: сравнение клинико-демографических характеристик пациентов (по данным национального регистра артериальной гипертонии, 2019-2022 гг.). Системные гипертензии. 2024;21(1):15-20. https://doi.org/10.38109/2075-082X-2024-1-15-20

150. Kritchevsky SB, Beavers KM, Miller ME, et al. Intentional weight loss and all-cause mortality: a meta-analysis of randomized clinical trials. PLoS One 2015; 10:e0121993. https://doi.org/10.1371/journal.pone.0121993

151. Hall ME, Cohen JB, Ard JD, et al. Weight-Loss Strategies for Prevention and Treatment of Hypertension: A Scientific Statement From the American Heart Association. Hypertension (Dallas, Tex: 1979) 2021;78:e38–e50. https://doi.org/10.1161/hyp.0000000000000202

152. Стародубова А.В., Ливанцова Е.Н., Дербенева С.А. и соавт. Кардионутрициология: лечебное питание в профилактике и лечении ведущей патологии современности. Вопросы питания. – 2020. – Т. 89, № 4. – С. 146-160. https://doi.org/10.24411/0042-8833-2020-10049

153. Filippou CD, Thomopoulos CG, Kouremeti MM, et al. Mediterranean diet and blood pressure reduction in adults with and without hypertension: A systematic review and meta-analysis of randomized controlled trials. Clin Nutr 2021; 40:3191–3200. https://doi.org/10.1016/j.clnu.2021.01.030

154. Filippou CD, Tsioufis CP, Thomopoulos CG, et al. Dietary Approaches to Stop Hypertension (DASH) Diet and Blood Pressure Reduction in Adults with and without Hypertension: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Adv Nutr 2020; 11:1150–1160. https://doi.org/10.1093/advances/nmaa041

155. Soltani S, Arablou T, Jayedi A, Salehi-Abargouei A. Adherence to the dietary approaches to stop hypertension (DASH) diet in relation to all-cause and cause-specific mortality: a systematic review and dose-response meta-analysis of prospective cohortstudies. Nutr J 2020; 19:37. https://doi.org/10.1186/s12937-020-00554-8

156. Sofi F, Abbate R, Gensini GF, Casini A. Accruing evidence on benefits of adherence to the Mediterranean diet on health: an updated systematic review and meta-analysis. Am J ClinNutr 2010; 92:1189–1196. https://doi.org/10.3945/ajcn.2010.29673

157. Dinu M, Pagliai G, Angelino D, et al. Effects of Popular Diets on Anthropometric and Cardiometabolic Parameters: An Umbrella Review of Meta-Analyses of Randomized Controlled Trials. Adv Nutr 2020; 11:815–833. https://doi.org/10.1093/advances/nmaa006

158. Borghi C. Coffee and blood pressure: exciting news! Blood Press 2022; 31:284–287. https://doi.org/10.1080/08037051.2022.2136621

159. Guessous I, Dobrinas M, Kutalik Z, et al. Caffeine intake and CYP1A2 variants associated with high caffeine intake protect non-smokers from hypertension. Hum Mol Genet 2012; 21:3283–3292. https://doi.org/10.1093/hmg/dds137

160. Huang L, Trieu K, Yoshimura S, et al. Effect of dose and duration of reduction in dietary sodium on blood pressure levels: systematic review and meta-analysis of randomised trials. BMJ 2020; 368:m315. https://doi.org/10.1136/bmj.m315

161. Mente A, O’Donnell M, Rangarajan S, et al. Associations of urinary sodium excretion with cardiovascular events in individuals with and without hypertension: a pooled analysis of data from four studies. Lancet 2016; 388:465–475. https://doi.org/10.1016/s0140-6736(16)30467-6

162. Lee HY, Shin J, Kim GH et al. 2018 Korean Society of Hypertension Guidelines for the management of hypertension: part II-diagnosis and treatment of hypertension. Clin Hypertens. 2019 Aug 1:25:20. https://doi.org/10.1186/s40885-019-0124-x

163. Graudal NA, Hubeck-Graudal T, Jürgens G. Effects of low-sodium diet vs. high-sodium diet on blood pressure, renin, aldosterone, catecholamines, cholesterol, and triglyceride (Cochrane Review). Am J Hypertens 2012; 25:1-15. https://doi.org/10.1038/ajh.2011.210

164. Neal B, Wu Y, Feng X, et al. Effect of Salt Substitutionon Cardiovascular Events and Death. N Engl J Med 2021; 385:1067-1077. https://doi.org/10.1056/nejmoa2105675

165. Tsai YC, Tsao YP, Huang CJ, et al. Effectiveness of salt substitute on cardiovascular outcomes: A systematic review and metaanalysis. J Clin Hypertens (Greenwich) 2022; 24:1147-1160. https://doi.org/10.1111/jch.14562

166. Методические рекомендации MP 2.3.1.0253-21. «Нормы физиологических потребностей в энергии и пищевых веществах для различных групп населения Российской Федерации» (утв. Федеральной службой по надзору в сфере защиты прав потребителей и благополучия человека 22 июля 2021 г.).

167. Poorolajal J, Zeraati F, Soltanian AR, et al. Oral potassium supplementation for management of essential hypertension: A meta-analysis of randomized controlled trials. PLoS One 2017; 12:e0174967. https://doi.org/10.1371/journal.pone.0174967

168. Aburto NJ, Hanson S, Gutierrez H, et al. Effect of increased potassium intake on cardiovascular risk factors and disease: systematic review and meta-analyses. BMJ 2013; 346:f1378. https://doi.org/10.1136/bmj.f1378

169. Стабильная ишемическая болезнь сердца. Клинические рекомендации 2020. Российский кардиологический журнал. 2020;25(11):4076. https://doi.org/10.15829/1560-4071-2020-4076

170. Бойцов С. А., Погосова Н. В., Аншелес А.А. и соавт. Кардиоваскулярная профилактика 2022. Российские национальные рекомендации. Российский кардиологический журнал. 2023;28(5):5452. EDN EUDWYG. https://doi.org/10.15829/1560-4071-2023-5452

171. Visseren FLJ, Mach F, Smulders YM, et al.;ESC National Cardiac Societies; ESC Scientific Document Group. 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice. Eur Heart J. 2021;42(34):3227-3337. https://doi.org/10.1093/eurheartj/ehab484

172. Dietary Guidance for Cardiovascular Health: Consensus andControversies. Nutrients 2023;15(19):4295. https://doi.org/10.3390/nu15194295

173. Ежов М.В., Кухарчук В.В., Сергиенко И.В. и соавт. Нарушения липидного обмена. Клинические рекомендации 2023. Российский кардиологический журнал. 2023;28(5):5471. EDN YVZOWJ. https://doi.org/10.15829/1560-4071-2023-5471

174. Нутрициология и клиническая диетология: национальное руководство / под ред. В.А. Тутельяна, Д.Б. Никитюка. – 2-е изд. – Москва: ГЭОТАР-Медиа, 2021. – 1008 с.: ил. – (Серия «Национальные руководства»). ISBN: 978-5-9704-6280-5

175. GBD 2017 Diet Collaborators. Health effects of dietary risks in 195 countries, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2019;393:1958-72. https://doi.org/10.1016/S0140-6736(19)30041-8

176. World Cancer Research Fund/American Institute for Cancer Research. Third Expert Report Food, Nutrition, Physical Activity, and the Prevention of Cancer: a Global Perspective. Continuous Update Project Expert Report 2018. https://www.wcrf.org/dietandcancer

177. Применение специализированных пищевых продуктов в диетотерапии больных с кардиоваскулярной патологией / под ред. С.А. Дербеневой, А. В. Погожевой. – СПб.: Наукоемкие технологии, 2021. – 187 с. ISBN: 978-5-6045558-6-6

178. Guasch-Ferre M, Satija A, Blondin SA, et al. Meta-Analysis of Randomized Controlled Trials of Red Meat Consumption in Comparison With Various Comparison Diets on Cardiovascular Risk Factors. Circulation 2019;139:1828 1845. https://doi. org/10.1161/circulationaha.118.035225

179. Li Y, Hruby A, Bernstein AM, et al. Saturated Fats Compared With Unsaturated Fats and Sources of Carbohydrates in Relation to Risk of Coronary Heart Disease: A Prospective Cohort Study. J Am Coll Cardiol. 2015 Oct 6;66(14):1538-1548. https://doi.org/10.1016/j.jacc.2015.07.055

180. 2021 Dietary Guidance to Improve Cardiovascular Health: A Scientific Statement From the American Heart Association. Circulation. 2021;144:e472–e487. https://doi.org/10.1161/CIR.0000000000001031

181. Timmis A, Townsend N, Gale CP et al. European Society of Cardiology: Cardiovascular Disease Statistics 2019. Eur Heart J. 2020;41(1):12-85. https://doi.org/10.1093/eurheartj/ehz859

182. Montone RA, Camilli M, Calvieri C et al. Exposome in ischaemic heart disease: beyond traditional risk factors. Eur Heart J 2024;45:419-438. https://doi.org/10.1093/eurheartj/ehae001

183. Meier T, Gräfe K, Senn F et al. Cardiovascular mortality attributable to dietary risk factors in 51 countries in the WHO European Region from 1990 to 2016: a systematic analysis of the Global Burden of Disease Study. Eur J Epidemiol. 2019;34(1):37-55. https://doi.org/10.1007/s10654-018-0473-x

184. Cahill LE, Chiuve SE, Mekary RA et al. Prospective study of breakfast eating and incident coronary heart disease in a cohort of male US health professionals. Circulation. 2013;128(4):337-43. https://doi.org/10.1161/CIRCULATIONAHA.113.001474

185. Sharma K, Shah K, Brahmbhatt P, Kandre Y. Skipping breakfast and the risk of coronary artery disease. QJM 2018;111(10):715-719. https://doi.org/10.1093/qjmed/hcy162

186. Концевая А.В., Муканеева Д.К., Мырзаматова А.О. и соавт. Экономический ущерб факторов риска, обусловленный их вкладом в заболеваемость и смертность от основных хронических неинфекционных заболеваний в Российской Федерации в 2016 году. Кардиоваскулярная терапия и профилактика. 2020;19(1):2396. https://doi.org/10.15829/1728-8800-2020-1-2396

187. Santos RD, Gidding SS, Hegele RA et al. Defining severe familial hypercholesterolaemia and the implications for clinical management: a consensus statement from the International Atherosclerosis Society Severe Familial Hypercholesterolemia Panel. Lancet Diabetes Endocrinol. 2016;4(10):850-61. https://doi.org/10.1016/S2213-8587(16)30041-9

188. de Lorgeril M, Salen P, Martin J-L et al. Mediterranean Diet, Traditional Risk Factors, and the Rate of Cardiovascular Complications After Myocardial Infarction. Circulation. 1999;99(6):779-85. https://doi.org/10.1161/01.cir.99.6.779

189. Zhao M, Xiao M, Tan Q et al. Association between dietary omega-3 intake and coronary heart disease among American adults: The NHANES, 1999-2018. PLoS One. 2023 Dec 20;18(12):e0294861. https://doi.org/10.10.1371/journal.pone.0294861

190. Zheng J, Huang T, Yu Y et al. Fish consumption and CHD mortality: an updated meta-analysis of seventeen cohort studies. Public Health Nutrition. 2012;15(4):725-737. https://doi.org/10.1017/S1368980011002254

191. Gao Z, Zhang D, Yan X et al. Effects of ω-3 Polyunsaturated Fatty Acids on Coronary Atherosclerosis and Inflammation: A Systematic Review and Meta-Analysis. Front Cardiovasc Med. 2022;9:904250. https://doi.org/10.3389/fcvm.2022.904250

192. Marchioli R. Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. The Lancet. 1999;354(9177):447-455. https://doi.org/10.1016/S0140-6736(99)07072-5

193. Мареев Ю.В., Ежов М.В., Виллевальде С.В. и соавт. Сердечно-сосудистые эффекты применения ω-3 полиненасыщенных жирных кислот: позиция ω-3 полиненасыщенных жирных кислот в Российских и международных рекомендациях. Совет экспертов. Кардиология. 2023;63(2). https://doi.org/10.18087/cardio.2023.2.n2388

194. Bhatt DL, Steg PG, Miller M et al. Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia. The New England Journal of Medicine. 2019;380(1):11-22. https://doi.org/10.1056/NEJMoa1812792

195. Lázaro I, Rueda F, Cediel G et al. Circulating Omega-3 Fatty Acids and Incident Adverse Events in Patients With Acute Myocardial Infarction. Journal of the American College of Cardiology 2020;76(18):2089-2097. https://doi.org/10.1016/j.jacc.2020.08.073

196. Нутрициология и клиническая диетология. Национальное руководство. Под редакцией В.А. Тутельяна, Д.Б. Никитюка. М., Гэотар-Медиа. 2020 г. 656 С. ISBN 978-5-9704-5352-0

197. Yusuf S, Hawken S, Ounpuu S et al.; INTERHEART Study Investigators. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet. 2004 Sep 11-17;364(9438):937-52. https://doi.org/10.1016/S0140-6736(04)17018-9204

198. Menotti A, Puddu PE. How the Seven Countries Study contributed to the definition and development of the Mediterranean diet concept: a 50-year journey. Nutr Metab Cardiovasc Dis. 2015;25(3):245-52. https://doi.org/10.1016/j.numecd.2014.12.001

199. Miller V, Mente A, Dehghan M et al. Prospective Urban Rural Epidemiology (PURE) study investigators. Fruit, vegetable, and legume intake, and cardiovascular disease and deaths in 18 countries (PURE): a prospective cohort study. Lancet. 2017;390(10107):2037-2049. https://doi.org/10.1016/S0140-6736(17)32253-5

200. Aune D, Keum N, Giovannucci E et al. Whole grain consumption and risk of cardiovascular disease, cancer, and all cause and cause specific mortality: systematic review and dose-responsemeta-analysis of prospective studies. BMJ. 2016;353:i2716. https://doi.org/10.1136/bmj.i2716

201. Kris-Etherton P, Eckel RH, Howard BV et al. Nutrition Committee Population Science Committee and Clinical Science Committee of the American Heart Association. AHA Science Advisory: Lyon Diet Heart Study. Benefits of a Mediterranean-style, National Cholesterol Education Program/American Heart Association Step I Dietary Pattern on Cardiovascular Disease. Circulation. 2001;103(13):1823-5. https://doi.org/10.1161/01.cir.103.13.1823

202. Chiavaroli L, Viguiliouk E, Nishi SK et al. DASH Dietary Pattern and Cardiometabolic Outcomes: An Umbrella Review of Systematic Reviews and Meta-Analyses. Nutrients. 2019;11(2):338. https://doi.org/10.3390/nu11020338

203. Campos CL, Wood A, Burke GL et al. Dietary Approaches to Stop Hypertension Diet Concordance and Incident Heart Failure: The Multi-Ethnic Study of Atherosclerosis. Am J Prev Med. 2019;56(6):819-826. https://doi.org/10.1016/j.amepre.2018.11.022

204. Henzel J, Kępka C, Kruk M et al. High-Risk Coronary Plaque Regression After Intensive Lifestyle Intervention in Nonobstructive Coronary Disease: A Randomized Study. JACC Cardiovasc Imaging. 2021;14(6):1192-1202. https://doi.org/10.1016/j.jcmg.2020.10.019

205. Satija A, Bhupathiraju SN, Spiegelman D et al. Healthful and Unhealthful Plant-Based Diets and the Risk of Coronary Heart Disease in U.S. Adults. J Am Coll Cardiol. 2017;70(4):411-422. https://doi.org/10.1016/j.jacc.2017.05.047

206. Jabri A, Kumar A, Verghese E et al. Meta-analysis of effect of vegetarian diet on ischemic heart disease and all-cause mortality. Am J Prev Cardiol. 2021 Apr 9;7:100182. https://doi.org/10.1016/j.ajpc.2021.100182

207. Ткачева О.Н., Тутельян В.А., Шестопалов А.Е., и соавт. Недостаточность питания (мальнутриция) у пациентов пожилого и старческого возраста. Клинические рекомендации. Российский журнал гериатрической медицины. 2021;(1):15-34. https://doi.org/10.37586/2686-8636-1-2021-15-34

208. Диетология. 5-е изд. Под редакцией А.Ю. Барановского — СПб.: Питер, 2017. — 1104 с. ISBN: 978-5-496-02276-7

209. Billingsley HE, Hummel SL, Carbone S. The role of diet and nutrition in heart failure: A state-of-the-art narrative review. Prog Cardiovasc Dis. 2020;63(5):538-551. https://doi.org/10.1016/j.pcad.2020.08.004

210. Нутрициология и клиническая диетология: национальное руководство / под ред. В. А. Тутельяна, Д. Б. Никитюка. – 2-е изд. – Москва: ГЭОТАР-Медиа, 2022. - 1008 с.: ил. (Серия "Национальные руководства").

211. Vest AR, Chan M, Deswal A et al. Nutrition, Obesity, and Cachexia in Patients With Heart Failure: A Consensus Statement from the Heart Failure Society of America Scientific Statements Committee. J Card Fail. 2019;25(5):380-400. https://doi.org/10.1016/j.cardfail.2019.03.007

212. Machado d’Almeida KS, Rabelo-Silva ER, Souza GC et al. Aggressive fluid and sodium restriction in decompensated heart failure with preserved ejection fraction: Results from a randomized clinical trial. Nutrition. 2018;54:111-117. https://doi.org/10.1016/j.nut.2018.02.007

213. Mahtani KR, Heneghan C, Onakpoya I et al. Reduced Salt Intake for Heart Failure: A Systematic Review. JAMA Intern. Med. 2018; 178:1693–1700. https://doi.org/10.1001/jamainternmed.2018.4673

214. Ezekowitz JA, Colin-Ramirez E, Ross H et al; SODIUM-HF Investigators. Reduction of dietary sodium to less than 100 mmol in heart failure (SODIUM-HF): an international, open-label, randomised, controlled trial. Lancet. 2022;399(10333):1391-1400. https://doi.org/10.1016/S0140-6736(22)00369-5

215. Hermel M, Tsai S, Dlouhy L et al. Highlights of Cardiovascular Disease Prevention Studies Presented at the 2022 American College of Cardiology Scientific Sessions. Curr Atheroscler Rep. 2022;24(8):671-680. https://doi.org/10.1007/s11883-022-01042-6

216. Urban S, Fułek M, Błaziak M et al. Role of dietary sodium restriction in chronic heart failure: systematic review and meta-analysis. Clin Res Cardiol. 2024;113(9):1331-1342. https://doi.org/10.1007/s00392-023-02256-7

217. Doukky R, Avery E, Mangla A et al. Impact of Dietary Sodium Restriction on Heart Failure Outcomes. JACC Hear Fail. 2016;4(1):24–35. https://doi.org/10.1016/j.jchf.2015.08.007

218. Khan MS, Jones DW, Butler J. Salt, No Salt, or Less Salt for Patients With Heart Failure? Am J Med. 2020;133(1):32–38. https://doi.org/10.1016/j.amjmed.2019.07.034

219. Patel Y, Joseph J. Sodium Intake and Heart Failure. Int J Mol Sci. 2020;21(24):9474. https://doi.org/10.3390/ijms21249474

220. Miller WL, Borgeson DD, Grantham JA et al. Dietary sodium modulation of aldosterone activation and renal function during the progression of experimental heart failure. Eur. J. Heart Fail. 2015;17:144-150. https://doi.org/10.1002/ejhf.212

221. Wittczak A, Ślot M, Bielecka-Dabrowa A. The Importance of Optimal Hydration in Patients with Heart Failure-Not Always Too Much Fluid. Biomedicines. 2023 Sep 30;11(10):2684. https://doi.org/10.3390/biomedicines11102684

222. Lennie T.A., Andreae C., Rayens M.K., et al. Micronutrient Deficiency Independently Predicts Time to Event in Patients With Heart Failure. J Am Heart Assoc. 2018;7(17):e007251. https://doi.org/10.1161/JAHA.117.007251

223. Song EK, Kang SM. Micronutrient Deficiency Independently Predicts Adverse Health Outcomes in Patients With Heart Failure. J CardiovascNurs. 2017;32(1):47-53. https://doi.org/10.1097/JCN.0000000000000304

224. Tappia PS, Lopez R, Fitzpatrick-Wong S, Ramjiawan B. Understanding the Role of Vitamin D in Heart Failure. Rev Cardiovasc Med. 2023 Apr 17;24(4):111. https://doi.org/10.31083/j.rcm2404111

225. Cvetinovic N, Loncar G, Isakovic AM, von Haehling S, Doehner W, Lainscak M, Farkas J. Micronutrient Depletion in Heart Failure: Common, Clinically Relevant and Treatable. Int J Mol Sci. 2019 Nov 11;20(22):5627. https://doi.org/10.3390/ijms20225627

226. Bomer N, Pavez-Giani MG, Grote Beverborg N, Cleland JGF, van Veldhuisen DJ, van der Meer P. Micronutrient deficiencies in heart failure: Mitochondrial dysfunction as a common pathophysiological mechanism? J Intern Med. 2022 Jun;291(6):713-731. https://doi.org/10.1111/joim.13456

227. Kkeveetil CV, Thomas G, Chander SJU. Role of micronutrients in congestive heart failure: A systematic review of randomized controlled trials. Ci Ji Yi Xue Za Zhi. 2016 Oct-Dec;28(4):143-150. https://doi.org/10.1016/j.tcmj.2016.08.001

228. Cascino TM, Hummel SL. Nutrient Deficiencies in Heart Failure: A Micro Problem With Macro Effects? J Am Heart Assoc. 2018 Sep 4;7(17):e010447. https://doi.org/10.1161/JAHA.118.010447

229. Cicero AFG, Colletti A, von Haehling S, Vinereanu D, Bielecka-Dabrowa A, Sahebkar A, Toth PP, Reiner Ž, Wong ND, Mikhailidis DP, Ferri C, Banach M; International Lipid Expert Panel. Nutraceutical support in heart failure: a position paper of the International Lipid Expert Panel (ILEP). Nutr Res Rev. 2020 Jun;33(1):155-179. https:// doi.org/10.1017/S0954422420000049

230. Хроническая сердечная недостаточность. Клинические рекомендации, 2024. https://РубрикаторКР (minzdrav.gov.ru).

231. Ponikowski P, Kirwan BA, Anker SD, et al.; AFFIRM-AHF investigators. Ferric carboxymaltose for iron deficiency at discharge after acute heart failure: a multicentre, double-blind, randomised, controlled trial. Lancet. 2020 Dec 12;396(10266):1895-1904. https://doi.org/10.1016/S0140-6736(20)32339-4

232. Ponikowski P, Mentz RJ, Hernandez AF, Butler J, Khan MS, van Veldhuisen DJ, Roubert B, Blackman N, Friede T, Jankowska EA, Anker SD. Efficacy of ferric carboxymaltose in heart failure with iron deficiency: an individual patient data meta-analysis. Eur Heart J. 2023 Dec 21;44(48):5077-5091. https://doi.org/10.1093/eurheartj/ehad586

233. Vukadinović D, Abdin A, Emrich I, Schulze PC, von Haehling S, Böhm M. Efficacy and safety of intravenous iron repletion in patients with heart failure: a systematic review and meta-analysis. Clin Res Cardiol. 2023 Jul;112(7):954-966. https://doi.org/10.1007/s00392-023-02207-2

234. Tang WHW, Li DY, Hazen SL. Dietary metabolism, the gut microbiome, and heart failure. Nat Rev Cardiol. 2019;16(3):137-154. https://doi.org/10.1038/s41569–018–0108–7

235. Sandek A, Doehner W, Anker SD, von Haehling S. Nutrition in heart failure: an update. Curr Opin Clin Nutr Metab Care. 2009;12(4):384-91. https://doi.org/10.1097/MCO.0b013e32832cdb0f

236. Gong F, Yao S, Wan J et al. Chocolate Consumption and Risk of Heart Failure: A Meta-Analysis of Prospective Studies. Nutrients. 2017;9(4):402. https://doi.org/10.3390/nu9040402

237. Bechthold A, Boeing H, Schwedhelm C et al. Food groups and risk of coronary heart disease, stroke and heart failure: A systematic review and dose-response meta-analysis of prospective studies. CritRevFoodSciNutr. 2019;59(7):1071–1090. https://doi.org/10.1080/10408398.2017.1392288

238. Wirth J, di Giuseppe R, Boeing H et al. A Mediterranean-style diet, its components and the risk of heart failure: a prospective populationbased study in a non-Mediterranean country. Eur J Clin Nutr. 2016;70(9):1015-21. https://doi.org/10.1038/ejcn.2016.140

239. Mozaffarian D, Gottdiener JS, Siscovick DS. Intake of tuna or other broiled or baked fish versus fried fish and cardiac structure, function, and hemodynamics. Am J Cardiol. 2006;97(2):216-22. https://doi.org/10.1016/j.amjcard.2005.08.025

240. Kerley CP. Dietary patterns and components to prevent and treat heart failure: a comprehensive review of human studies. Nutr Res Rev. 2019 Jun;32(1):1-27. https://doi.org/10.1017/S0954422418000148

241. Butler T. Dietary management of heart failure: room for improvement? Br J Nutr. 2016 Apr 14;115(7):1202-17. https://doi.org/10.1017/S000711451500553X

242. Dos Reis Padilha G, Sanches Machado d'Almeida K, Ronchi Spillere S, Corrêa Souza G. Dietary Patterns in Secondary Prevention of Heart Failure: A Systematic Review. Nutrients. 2018 Jun 26;10(7):828. https://doi.org/10.3390/nu10070828

243. Wickman BE, Enkhmaa B, Ridberg R, Romero E, Cadeiras M, Meyers F, Steinberg F. Dietary Management of Heart Failure: DASH Diet and Precision Nutrition Perspectives. Nutrients. 2021 Dec 10;13(12):4424. https://doi.org/10.3390/nu13124424

244. Driggin E, Cohen LP, Gallagher D, Karmally W, Maddox T, Hummel SL, Carbone S, Maurer MS. Nutrition Assessment and Dietary Interventions in Heart Failure: JACC Review Topic of the Week. J Am Coll Cardiol. 2022 Apr 26;79(16):1623-1635. https://doi.org/10.1016/j.jacc.2022.02.025

245. Abu-Sawwa R, Dunbar SB, Quyyumi AA, Sattler ELP. Nutrition intervention in heart failure: should consumption of the DASH eating pattern be recommended to improve outcomes? Heart Fail Rev. 2019 Jul;24(4):565-573. https://doi.org/10.1007/s10741-019-09781-6

246. Ishikawa Y, Sattler ELP. Nutrition as Treatment Modality in Heart Failure. Curr Atheroscler Rep. 2021;23(4):13. https://doi.org/10.1007/s11883-021-00908-5

247. Khawaja O, Singh H, Luni F et al. Egg Consumption and Incidence of Heart Failure: A Meta-Analysis of Prospective Cohort Studies. FrontNutr. 2017;4:10. https://doi.org/10.3389/fnut.2017.00010

248. Djoussé L, Gaziano JM. Egg consumption and risk of heart failure in the Physicians' Health Study. Circulation. 2008;117(4):512-6. https://doi.org/10.1161/CIRCULATIONAHA.107.734210

249. Larsson SC, Åkesson A, Wolk A. Egg consumption and risk of heart failure, myocardial infarction, and stroke: results from 2 prospective cohorts. AmJClinNutr. 2015;102(5):1007-13. https://doi.org/10.3945/ajcn.115.119263

250. Godos J, Micek A, Brzostek T et al. Egg consumption and cardiovascular risk: a dose-response meta-analysis of prospective cohort studies. Eur J Nutr 2021;60:1833-62.https://doi.org/10.1007/s00394-020-02345-7

251. Virtanen JK, Larsson SC. Eggs – a scoping review for Nordic Nutrition Recommendations 2023. Food Nutr Res. 2024;68. https://doi.org/10.29219/fnr.v68.10507

252. Ashaye A, Gaziano J, Djoussé L. Red meat consumption and risk of heart failure in male physicians. NutrMetab Cardiovasc Dis. 2011;21(12):941-6. https://doi.org/10.1016/j.numecd.2010.03.009

253. Kaluza J, Åkesson A, Wolk A. Long-term processed and unprocessed red meat consumption and risk of heart failure: A prospective cohort study of women. Int J Cardiol. 2015 Aug 15;193:42-6. https://doi.org/10.1016/j.ijcard.2015.05.044

254. Cui K, Liu Y, Zhu L et al. Association between intake of red and processed meat and the risk of heart failure: a meta-analysis. BMC Public Health 2019 Mar 29; 19(1): 354. https://doi.org/10.1186/s12889-019-6653-0

255. Meinilä J, Virtanen JK. Meat and meat products – a scoping review for Nordic Nutrition Recommendations 2023. FoodNutrRes. 2024;68. https://doi.org/10.29219/fnr.v68.10538

256. Heidenreich PA, Park SM, Kang SM. Lifestyle Modification in Heart Failure Management: Are We Using Evidence-Based Recommendations in Real World Practice? Int J Heart Fail. 2023;5(1):21-33. https://doi.org/10.36628/ijhf.2022.0032

257. Ibsen DB, Levitan EB, Åkesson A et al. The DASH diet is associated with a lower risk of heart failure: a cohort study. Eur J Prev Cardiol. 2022;29(7):1114-1123. https://doi.org/10.1093/eurjpc/zwac003

258. Rifai L, Silver MA. A Review of the DASH Diet as an Optimal Dietary Plan for Symptomatic Heart Failure. Prog Cardiovasc Dis. 2016 Mar-Apr;58(5):548-554. https://doi.org/10.1016/j.pcad.2015.11.001

259. Rifai L, Pisano C, Hayden J et al. Impact of the DASH diet on endothelial function, exercise capacity, and quality of life in patients with heart failure. Proc (Bayl Univ Med Cent). 2015;28(2):151-6. https://doi.org/10.1080/08998280.2015.11929216

260. Hummel SL, Seymour EM, Brook RD et al. Low-sodium DASH diet improves diastolic function and ventricular-arterial coupling in hypertensive heart failure with preserved ejection fraction. Circ Heart Fail. 2013;6(6):1165-71. https://doi.org/10.1161/CIRCHEARTFAILURE.113.000481

261. Ishikawa Y, Laing EM, Anderson AK et al. Adherence to the Dietary Approaches to Stop Hypertension (DASH) diet is associated with low levels of insulin resistance among heart failure patients. NutrMetabCardiovascDis. 2022;32(8):1841-1850. https://doi.org/10.1016/j.numecd.2022.04.018

262. Hummel SL, Karmally W, Gillespie BW, Helmke S, Teruya S, Wells J, Trumble E, Jimenez O, Marolt C, Wessler JD, Cornellier ML, Maurer MS. Home-Delivered Meals Postdischarge From Heart Failure Hospitalization. Circ Heart Fail. 2018 Aug;11(8):e004886. https://doi.org/10.1161/CIRCHEARTFAILURE.117.004886

263. Levitan EB, Lewis CE, Tinker LF et al. Medi terranean and DASH diet scores and mortality in women with heart failure: The Women’s Health Initiative. Circ Heart Fail. 2013;6(6):1116-23. https://doi.org/10.1161/CIRCHEARTFAILURE.113.000495

264. de Lorgeril M, Salen P, Martin JL et al. Mediterranean diet, traditional risk factors, and the rate of cardiovascular complications after myocardial infarction: final report of the Lyon Diet Heart Study. Circulation. 1999;99(6):779-85. https://doi.org/10.1161/01.cir.99.6.779

265. Liyanage T, Ninomiya T, Wang A et al. Effects of the Mediterranean Diet on Cardiovascular Outcomes-A Systematic Review and Meta-Analysis. PLoS One. 2016;11(8): e0159252. https://doi.org/10.1371/journal.pone.0159252

266. Fito M, Estruch R, Salas-Salvado J et al. PREDIMED Study Investigators. Effect of the Mediterranean diet on heart failure biomarkers: a randomized sample from the PREDIMED trial. EurJHeartFail. 2014;16(5):543-50. https://doi.org/10.1002/ejhf.61

267. Herrera-Martínez AD, Muñoz Jiménez C, López Aguilera J et al. Mediterranean Diet, Vitamin D, and Hypercaloric, Hyperproteic Oral Supplements for Treating Sarcopenia in Patients with Heart Failure-A Randomized Clinical Trial. Nutrients. 2023;16(1):110. https://doi.org/10.3390/nu16010110

268. Lara KM, Levitan EB, Gutierrez OM et al. Dietary Patterns and Incident Heart Failure in U.S. Adults Without Known Coronary Disease. JAmCollCardiol. 2019;73(16):2036-2045. https://doi.org/10.1016/j.jacc.2019.01.067

269. Rautiainen S, Levitan EB, Mittleman MA et al. Fruit and vegetable intake and rate of heart failure: a population-based prospective cohort of women. EurJHeartFail. 2015;17(1):20-6. https://doi.org/10.1002/ejhf.191

270. Djoussé L, Gaziano JM. Alcohol consumption and heart failure: a systematic review. Curr Atheroscler Rep. 2008 Apr;10(2):117-20. https://doi.org/10.1007/s11883-008-0017-z

271. Rasoul D, Ajay A, Abdullah A, Mathew J, Lee Wei En B, Mashida K, Sankaranarayanan R. Alcohol and Heart Failure. Eur Cardiol. 2023 Dec 26;18:e65. https://doi.org/10.15420/ecr.2023.12

272. Парентеральное и энтеральное питание: национальное руководство под ред. С. С. Петриков, М. Ш. Хубутия, Т. С. Попова. 2-е изд., перераб. и доп. Москва: ГЭОТАР-Медиа, 2023.1168 с. Глава 27. Нутритивная поддержка пациентов с сердечно-сосудистыми заболеваниями. С. 563-580 (Серия «Национальные руководства»). ISBN: 978-5-9704-7277-4

273. Kerley CP. Nutritional Interventions in Heart Failure: Challenges and Opportunities. Curr Heart Fail Rep. 2018;15(3):131-140. https://doi.org/10.1007/s11897-018-0388-6

274. Evangelista LS, Jose MM, Sallam H et al. High-protein vs. standardprotein diets in overweight and obese patients with heart failure and diabetes mellitus: findings of the Pro-HEART trial. ESC Heart Fail. 2021;8(2):1342-1348. https://doi.org/10.1002/ehf2.13213

275. Dos Santos EM, Moreira ASB, Huguenin GVB et al. Effects of Whey Protein Isolate on Body Composition, Muscle Mass, and Strength of Chronic Heart Failure Patients: A Randomized Clinical Trial. Nutrients. 2023;15(10):2320. https://doi.org/10.3390/nu15102320

276. Bonilla-Palomas JL, Gámez-López AL, Castillo-Domínguez JC et al. Nutritional Intervention in Malnourished Hospitalized Patients with Heart Failure. Arch Med Res. 2016;47(7):535-540. https://doi.org/10.1016/j.arcmed.2016.11.005

277. MacDonald A, Hildebrandt L. Comparison of formulaic equations to determine energy expenditure in the critically ill patient. Nutrition. 2003;19(3):233-9. https://doi.org/10.1016/s0899-9007(02)01033-x

278. Abshire M, Xu J, Baptiste D et al. Nutritional Interventions in Heart Failure: A Systematic Review of the Literature. J Card Fail. 2015;21(12):989-99. https://doi.org/10.1016/j.cardfail.2015.10.004

279. Beasley JM, Shikany JM, Thomson CA. The role of dietary protein intake in the prevention of sarcopenia of aging. Nutr Clin Pract. 2013;28(6):684-90. https://doi.org/10.1177/0884533613507607

280. Sciatti E, Lombardi C, Ravera A et al. Nutritional Deficiency in Patients with Heart Failure. Nutrients. 2016;8(7):442. https://doi.org/10.3390/nu8070442

281. Kuehneman T, Gregory M, de Waal D et al. Academy of Nutrition and Dietetics Evidence-Based Practice Guideline for the Management of Heart Failure in Adults. J Acad Nutr Diet. 2018;118(12):2331-2345. https://doi.org/10.1016/j.jand.2018.03.004

282. Abdelhamid AS, BrownTJ, Brainard JS et al. Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease. Cochrane Database Syst Rev. 2018;7(7):CD003177. https://doi.org/10.1002/14651858.CD003177.pub3

283. Sakamoto A, Saotome M, Iguchi K, Maekawa Y. Marine-Derived Omega-3 Polyunsaturated Fatty Acids and Heart Failure: Current Understanding for Basic to Clinical Relevance. Int J Mol Sci. 2019 Aug 18;20(16):4025. https://doi.org/10.3390/ijms20164025

284. Barbarawi M, Lakshman H, Barbarawi O. Omega-3 supplementation and heart failure: A meta-analysis of 12 trials including 81,364 participants. Contemp Clin Trials. 2021;107:106458. https://doi.org/10.1016/j.cct.2021.106458

285. Chrysohoou C, Metallinos G, Georgiopoulos G et al. Short term omega-3 polyunsaturated fatty acid supplementation induces favorable changes in right ventricle function and diastolic filling pressure in patients with chronic heart failure; A randomized clinical trial. VasculPharmacol. 2016;79:43-50. https://doi.org/10.1016/j.vph.2016.01.005

286. Oikonomou E, Vogiatzi G, Karlis D et al. Eff ects of omega-3 polyunsaturated fatty acids on fibrosis, endothelial function and myocardial performance, in ischemic heart failure patients. ClinNutr. 2019;38(3):1188-1197. https://doi.org/10.1016/j.clnu.2018.04.017

287. O’Connell TD, Block RC, Huang SP et al. ω3-Polyunsaturated fatty acids for heart failure: Effects of dose on efficacy and novel signaling through free fatty acid receptor 4. J Mol Cell Cardiol. 2017;103:74-92. https://doi.org/10.1016/j.yjmcc.2016.12.003

288. He Y, Huang W, Zhang C et al. Energy metabolism disorders and potential therapeutic drugs in heart failure. Acta Pharm Sin B. 2021;11(5):1098-1116. https://doi.org/10.1016/j.apsb.2020.10.007

289. Endo J, Arita M. Cardioprotective mechanism of omega-3 polyunsaturated fatty acids. J Cardiol. 2016;67(1):22-7. https://doi.org/10.1016/j.jjcc.2015.08.002

290. Мареев ЮВ, Ежов МВ, Виллевальде СВ и соавт. Сердечно-сосудистые эффекты применения омега-3 полиненасыщенных жирных кислот: позиция омега-3 полиненасыщенных жирных кислот в Российских и международных рекомендациях. Совет экспертов. Кардиология. 2023;63(2):11-18. https://doi.org/10.18087/cardio.2023.2.n2388

291. Клинические рекомендации «Нарушения липидного обмена» 2023г. https://minzdrav.gov.ru

292. Gencer B, Djousse L, Al-Ramady OT, Cook NR, Manson JE, Albert CM. Effect of Long-Term Marine ɷ-3 Fatty Acids Supplementation on the Risk of Atrial Fibrillation in Randomized Controlled Trials of Cardiovascular Outcomes: A Systematic Review and Meta-Analysis. Circulation. 2021 Dec 21;144(25):1981-1990. https://doi.org/10.1161/CIRCULATIONAHA.121.055654

293. Quispe R, Alfaddagh A, Kazzi B, Zghyer F, Marvel FA, Blumenthal RS, Sharma G, Martin SS. Correction to: Controversies on the Use of Omega-3 Fatty Acids to Prevent Atherosclerosis. Curr Atheroscler Rep. 2022 Jul;24(7):583. https://doi.org/10.1007/s11883-022-01043-5 Erratum for: Curr Atheroscler Rep. 2022 Jul;24(7):571-581. https://doi.org/10.1007/s11883-022-01031-9

294. Mortensen SA, Rosenfeldt F, Kumar A et al. Q-SYMBIO Study Investigators. The effect of coenzyme Q10 on morbidity and mortality in chronic heart failure: results from Q-SYMBIO: a randomized double-blind trial. JACCHeartFail. 2014;2(6):641-649. https://doi.org/10.1016/j.jchf.2014.06.008

295. Lei L, Liu Y. Efficacy of coenzyme Q10 in patients with cardiac failure: a meta-analysis of clinical trials. BMC Cardiovasc Disord. 2017;17(1):196. https://doi.org/10.1186/s12872–017–0628–9

296. Sobirin MA, Herry Y, Sofia SN et al. Effects of coenzyme Q10 supplementation on diastolic function in patients with heart failure with preserved ejection fraction. Drug Discov Ther. 2019;13(1):38-46. https://doi.org/10.5582/ddt.2019.01004

297. Evans WJ, Morley JE, Argilés J et al. Cachexia: a new definition. Clin Nutr. 2008;27(6):793-9. https://doi.org/10.1016/j.clnu.2008.06.013

298. Cruz-Jentoft AJ, Bahat G, Bauer J et al. Writing Group for the European Working Group on Sarcopenia in Older People 2 (EWGSOP2), and the Extended Group for EWGSOP2. Sarcopenia: revised European consensus on definition and diagnosis. Age and Ageing. 2019;48(1):16-31. https://doi.org/10.1093/ageing/afy169

299. Kondrup J, Prokopowicz J, Schiesser M et al. EuroOOPS: an international, multicentre study to implement nutritional risk screening and evaluate clinic al outcome Clin Nutr. 2008;27(3):340-9. https://doi.org/10.1016/j.clnu.2008.03.012

300. Loncar G, Springer J, Anker M et al. Cardiac cachexia: hic et nunc. J Cachexia Sarcopenia Muscle. 2016;7(3):246-60. https://doi.org/10.1002/jcsm.12118

301. Anker MS, Holcomb R, Muscaritoli M et al. Orphan disease status of cancer cachexia in the USA and in the European Union: a systematic review. J Cachexia Sarcopenia Muscle. 2019;10(1):22-34. https://doi.org/10.1002/jcsm.12402

302. Valentova M, Anker SD, von Haehling S. Cardiac Cachexia Revisited. Heart Fail Clin.2020;16(1):61-9. https://doi.org/10.1016/j.hfc.2019.08.006

303. Ebner N, von Haehling S. Unlocking the wasting enigma: highlights from the 8th cachexia conference. J Cachexia Sarcopenia Muscle. 2016;7(1):90-94. https://doi.org/10.1002/jcsm.1210659

304. Tieland M, Trouwborst I, Clark BC. Skeletal muscle performance and ageing. J Cachexia Sarcopenia Muscle. 2018;9(1):3-19. https://doi.org/10.1002/jcsm.1223861

305. Bauer J, Morley JE, Schols AMWJ et al. Sarcopenia: A Time for Action. An SCWD Position Paper. J Cachexia Sarcopenia Muscle. 2019;10(5):956-961. https://doi.org/10.1002/jcsm.12483

306. Loncar G, Fülster S, von Haehling S et al. Metabolism and the heart: an overview of muscle, fat, and bone metabolism in heart failure. Int J Cardiol. 2013;162(2):77-85. https://doi.org/10.1016/j.ijcard.2011.09.079

307. Pacifico J, Geerlings MAJ, Reijnierse EM et al. Prevalence of sarcopenia as a comorbid disease: a systematic review and metaanalysis. Experimental Gerontology. 2020;131:110801. https://doi.org/10.1016/j.exger.2019.110801

308. Harris R, Chang Y, Beavers K et al. Risk of fracture in women with sarcopenia, low bone mass, or both. J Am Geriatr Soc. 2017;65(12):2673-2678. https://doi.org/10.1111/jgs.1505058

309. Brown JC, Harhay MO, Harhay MN. Sarcopenia and mortality among a population-based sample of community-dwelling older adults. J Cachexia Sarcopenia Muscle. 2016 Jun;7(3):290-8. https://doi.org/10.1002/jcsm.12073

310. Anker MS, von Haehling S, Springer J et al. Highlights of the mechanistic and therapeutic cachexia and sarcopenia research 2010 to 2012 and their relevance for cardiology. Int J Cardiol. 2013;162(2):73-6. https://doi.org/10.1016/j.ijcard.2012.10.018

311. Xu J, Wan CS, Ktoris K et al. Sarcopenia is associated with mortality in adults: a systematic review and meta-analysis. Gerontology. 2022;68(4):361-376. https://doi.org/10.1159/000517099

312. Gümüşsoy M, Atmış V, Yalçın A et al. Malnutrition-sarcopenia syndrome and all-cause mortality in hospitalized older people. Clinical Nutrition (Edinburg, Scotland). 2021;40(11):5475-5481. https://doi.org/10.1016/j.clnu.2021.09.036

313. Takahashi F, Hashimoto Y, Kaji A et al. Sarcopenia is associated with a risk of mortality in people with type 2 diabetes mellitus. Frontiers in Endocrinology. 2021;12:783363. https://doi.org/10.3389/fendo.2021.783363

314. Reber E, Gomes F, Vasiloglou MF, Schuetz P, Stanga Z. Nutritional Risk Screening and Assessment. J Clin Med. 2019 Jul 20;8(7):1065. https://doi.org/10.3390/jcm8071065

315. Argilés JM, Busquets S, Stemmler B, López-Soriano FJ. Cachexia and sarcopenia: mechanisms and potential targets for intervention. Curr Opin Pharmacol. 2015;22:100-6. https://doi.org/10.1016/j.coph.2015.04.003

316. Ali S, Garcia JM. Sarcopenia, cachexia and aging: diagnosis, mechanisms and therapeutic options-a mini-review. Gerontology. 2014;60(4):294-305. https://doi.org/10.1159/000356760

317. Donini LM, Poggiogalle E, Molfino A, Rosano A, Lenzi A, Rossi Fanelli F, Muscaritoli M. Mini-Nutritional Assessment, Malnutrition Universal Screening Tool, and Nutrition Risk Screening Tool for the Nutritional Evaluation of Older Nursing Home Residents. J Am Med Dir Assoc. 2016 Oct 1;17(10):959.e11-8. https://doi.org/10.1016/j.jamda.2016.06.028

318. Kinugasa Y, Sota T, Kamitani H, Nakayama N, Nakamura K, Hirai M, Yanagihara K, Kato M, Ono T, Takahashi M, Matsuo H, Matsukawa R, Yoshida I, Kakinoki S, Yonezawa K, Himura Y, Yokota T, Yamamoto K, Tsuchihashi-Makaya M, Kinugawa S. Diagnostic performance of nutritional indicators in patients with heart failure. ESC Heart Fail. 2022 Aug;9(4):2096-2106. https://doi.org/10.1002/ehf2.13886

319. Ramiro-Ortega E, Bonilla-Palomas JL, Gámez-López AL et al. Nutritional intervention in acute heart failure patients with undernutrition and normalbuminemia: A subgroup analysis of PICNIC study. Clin Nutr. 2018;37(5):1762-4. https://doi.org/10.1016/j.clnu.2017.07.009

320. Sze S, Pellicori P, Zhang J et al. The impact of malnutrition on short-term morbidity and mortality in ambulatory patients with heart failure. Am J Clin Nutr. 2021;113(3):695-705. https://doi.org/10.1093/ajcn/nqaa311

321. Bonilla Palomas JL, Gámez López AL, Moreno Conde M et al. Influencia de la desnutriciónsobre la mortalidad a largo plazoenpacientesambulatorios con insuficienciacardiacacrónica [Impact of malnutrition on long-term mortality in outpatients with chronic heart failure]. Nutr Hosp. 2017;34(5):1382-9. Spanish. https://doi.org/10.20960/nh.1131

322. Rahman A, Jafry S, Jeejeebhoy K et al. Malnutrition and cachexia in heart failure. JPEN J Parenter Enteral Nutr. 2016;40(4):475-486. https://doi.org/10.1177/0148607114566854

323. Pasini E, Aquilani R, Corsetti G et al. Malnutrition and Gut Flora Dysbiosis: Specific Therapies for Emerging Comorbidities in Heart Failure. Biomed Res Int. 2015;2015:382585. https://doi.org/10.1155/2015/382585

324. Arutyunov GP, Kostyukevich OI, Serov RA, Rylova NV, Bylova NA. Collagen accumulation and dysfunctional mucosal barrier of the small intestine in patients with chronic heart failure nt J Cardiol. 2008 Apr 10;125(2):240-5. https://doi.org/10.1016/j.ijcard.2007.11.103

325. Саликова С.П., Гриневич В.Б., Власов А.А. Современные аспекты питания при хронической сердечной недостаточности. Экспериментальная и клиническая гастроэнтерология. 2021;196(12):62-73. https://doi.org/10.31146/1682-8658-ecg-196-12-62-73

326. Yin J, Lu X, Qian Z, Xu W, Zhou X. New insights into the pathogenesis and treatment of sarcopenia in chronic heart failure. Theranostics. 2019 May 31;9(14):4019-4029. (In Russ.) https://doi.org/10.7150/thno.33000

327. Schaap LA, Pluijm SM, Deeg DJ, Harris TB, Kritchevsky SB, Newman AB, Colbert LH, Pahor M, Rubin SM, Tylavsky FA, Visser M; Health ABC Study. Higher inflammatory marker levels in older persons: associations with 5-year change in muscle mass and muscle strength. J Gerontol A Biol Sci Med Sci. 2009 Nov;64(11):1183-9. https://doi.org/10.1093/gerona/glp097

328. Gomes F, Schuetz P, Bounoure L, Austin P, et al. ESPEN guideline on nutritional support for polymorbid internal medicine patients. Clin Nutr 2018;37:336-353. https://doi.org/10.1016/j.clnu.2017.06.025

329. Volkert D, Beck AM, Cederholm T, Cruz-Jentoft A, et al. ESPEN guideline on clinical nutrition and hydration in geriatrics. Clin Nutr 2019;38:10-47. https://doi.org/10.1016/j.clnu.2018.05.024

330. Eng SH, Jaarsma T, Lupón J, González B, Ehrlin J, Díaz V, Bayes-Genis A, Waldréus N. Thirst and factors associated with frequent thirst in patients with heart failure in Spain. Heart Lung. 2021 Jan-Feb;50(1):86-91. Epub 2020 Aug 11. PMID: 32798064. https://doi.org/10.1016/j.hrtlng.2020.08.002

331. Ezekowitz JA. Fluid Restriction: Time to Let it Flow? J Card Fail. 2022 Sep;28(9):1480-1481. https://doi.org/10.1016/j.cardfail.2022.03.347

332. Sakamoto A, Saotome M, Iguchi K et al. Micronutrient Deficiency Independently Predicts Time to Event in Patients With Heart Failure. J Am Heart Assoc. 2018;7(17): e007251. https://doi.org/10.1161/JAHA.117.007251

333. Quispe R, Alfaddagh A, Kazzi B et al. Micronutrient Deficiency Independently Predicts Time to Event in Patients With Heart Failure. J Am Heart Assoc. 2018;7(17): e007251. https://doi.org/10.1161/JAHA.117.007251

334. Khan MS, Khan F, Fonarow GC et al. Dietary interventions and nutritional supplements for heart failure: a systematic appraisal and evidence map. EurJHeartFail. 2021;23:1468-1476. https://doi.org/10.1002/ejhf.2278

335. Gong F., Yao S., Wan J., Gan X. Chocolate Consumption and Risk of Heart Failure: A Meta-Analysis of Prospective Studies. Nutrients. 2017;9(4):402. https://doi.org/10.3390/nu9040402

336. Bechthold A., Boeing H., Schwedhelm C., et al. Food groups and risk of coronary heart disease, stroke and heart failure: A systematic review and dose-response meta-analysis of prospective studies. Crit Rev Food Sci Nutr. 2019; 59(7):1071–1090. https://doi.org/10.1080/10408398.2017.1392288

337. Mozaffarian D., Gottdiener J. S., Siscovick D. S. Intake of tuna or other broiled or baked fish versus fried fish and cardiac structure, function, and hemodynamics. Am J Cardiol. 2006;97(2):216–22. https://doi.org/10.1016/j.amjcard.2005.08.025

338. Kerley C.P. Nutritional Interventions in Heart Failure: Challenges and Opportunities. Curr Heart Fail Rep. 2018;15(3):131–140. https://doi.org/10.1007/s11897-018-0388-6

339. Heidenreich PA, Bozkurt B, Aguilar D et al. 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2022;145(18):e895-e1032. https://doi.org/10.1161/CIR.0000000000001063

340. D’Alessandro A., De Pergola G. The Mediterranean Diet: its definition and evaluation of a priori dietary indexes in primary cardiovascular prevention. Int J Food Sci Nutr. 2018;69(6):647-659. https://doi.org/10.1080/09637486.2017.1417978

341. Agha G, Loucks EB, Tinker LF et al. Healthy lifestyle and decreasing risk of heart failure in women: the Women’s Health Initiative observational study. JAmCollCardiol. 2014;64(17):1777-85. https://doi.org/10.1016/j.jacc.2014.07.981

342. Mijan de la Torre, A.; de Mateo Silleras, B.; AM, P.G. Nutricióne insuficiencia cardiaca. In Nutricione Insuficiencia Cardiaca En:Ángel Gil Tratado de Nutrición Tomo 5: Nutrición y Enfermedad, 3rd ed.; Panamericana: Madrid, Spain, 2017; pp. 705-728.

343. Hopper I., Connell C., Briffa T., et al. Nutraceuticals in Patients With Heart Failure: A Systematic Review. J Card Fail. 2020;26(2):166-179. https://doi.org/10.1016/j.cardfail.2019.10.014

344. Ikizler TA, Burrowes JD, Byham-Gray LD et al. KDOQI Clinical Practice Guideline for Nutrition in CKD: 2020 Update. American Journal of Kidney Diseases. 2020;76(3):S1-107. https://doi.org/10.1053/j.ajkd.2020.05.00

345. Chow SL, Bozkurt B, Baker WL, Bleske BE, et al.; American Heart Association Clinical Pharmacology Committee and Heart Failure and Transplantation Committee of the Council on Clinical Cardiology; Council on Epidemiology and Prevention; and Council on Cardiovascular and Stroke Nursing. Complementary and Alternative Medicines in the Management of Heart Failure: A Scientific Statement From the American Heart Association. Circulation. 2023Jan 10;147(2):e4-e30. Epub 2022 Dec 8. PMID: 36475715. https://doi.org/10.1161/CIR.0000000000001110

346. Rauf A, Imran M, Suleria HAR. A comprehensive review of the health perspectives of resveratrol. Food Funct. 2017;8:4284-4305. https://doi.org/10.1039/C7FO01300K

347. Raj P, Louis XL, Thandapilly SJ et al. Potential of resveratrol in the treatment of heart failure. LifeSci. 2014;95:63-71. https://doi.org/10.1016/j.lfs.2013.12.011

348. Wang HN, Li JL, Xu T et al. Effects of Sirt3-autophagy and resveratrol activation on myocardial hypertrophy and energy metabolism. Mol Med Rep. 2020;22(2):1342-1350. https://doi.org/10.3892/mmr.2020.11195

349. Cheng CK, Luo JY, Lau CW et al. Pharmacological basis and new insights of resveratrol action in the cardiovascular system. Br J Pharmacol. 2020;177(6):1258-1277. https://doi.org/10.1111/bph.14801

350. Dyck GJB, Raj P, Zieroth S et al. The Effects of Resveratrol in Patients with Cardiovascular Disease and Heart Failure: A Narrative Review. IntJMolSci. 2019 Feb 19;20(4):904. https://doi.org/10.3390/ijms20040904

351. Magyar K, Halmosi R, Palfi A et al. Cardioprotection by resveratrol: A human clinical trial in patients with stable coronary artery disease. Clin Hemorheol Microcirc. 2012;50(3):179-187. https://doi.org/10.3233/CH-2011-1424

352. Chekalina NI. Resveratrol has a positive effect on parameters of central hemodynamics and myocardial ischemia in patients with stable coronary heart disease. Wiad Lek. 2017;70(2 pt 2):286-291. PMID: 29059644

353. Gal R, Deres L, Horvath O et al. Resveratrol improves heart function by moderating inflammatory processes in patients with systolic heart failure. Antioxidants. 2020;9:1108. https://doi.org/10.3390/antiox9111108

354. Militaru C, Donoiu I, Craciun A et al. Oral resveratrol and calcium fructoborate supplementation in subjects with stable angina pectoris: Effects on lipid profiles, inflammation markers, and quality of life. Nutrition. 2013;29:178-183. https://doi.org/10.1016/j.nut.2012.07.006

355. Raj P, Thandapilly SJ, Wigle J et al. A Comprehensive Analysis of the Efficacy of Resveratrol in Atherosclerotic Cardiovascular Disease, Myocardial Infarction and Heart Failure. Molecules. 2021;26(21):6600. https://doi.org/10.3390/molecules26216600

356. Gal R, Praksch D, Kenyeres P et al. Hemorheological Alterations in Patients with Heart Failure with Reduced Ejection Fraction Treated by Resveratrol. CardiovascTher. 2020;2020:7262474. https://doi.org/10.1155/2020/7262474

357. Zordoky BNM, Robertson IM, Dyck JRB. Preclinical and clinical evidence for the role of resveratrol in the treatment of cardiovascular diseases. Biochem Biophys Acta. 2015;1852:1155-1177. https://doi.org/10.1016/j.bbadis.2014.10.016

358. Salmani M, Alipoor E, Navid H et al. Effect of l-arginine on cardiac reverse remodeling and quality of life in patients with heart failure. Clin Nutr. 2021;40(5):3037-3044. https://doi.org/10.1016/j.clnu.2021.01.044

359. Shiraseb F, Asbaghi O, Bagheri R, et al. Effect of l-Arginine Supplementation on Blood Pressure in Adults: A Systematic Review and Dose-Response Meta-analysis of Randomized Clinical Trials. Adv Nutr. 2022;13(4):1226-1242. https://doi.org/10.1093/advances/nmab155

360. 2023 AHA/ACC/ACCP/ASPC/NLA/PCNA Guideline for the Management of Patients With Chronic Coronary Disease: A Report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines Circulation 2023 Aug 29;148(9):e9-e119. Epub 2023 Jul 20. https://doi.org/10.1161/CIR.0000000000001168

361. Zhu B, Qi F, Wu J, Yin G, Hua J, Zhang Q, Qin L. Red Yeast Rice: A Systematic Review of the Traditional Uses, Chemistry, Pharmacology, and Quality Control of an Important Chinese Folk Medicine. Front Pharmacol. 2019 Dec 2;10:1449. https://doi.org/10.3389/fphar.2019

362. Ежов М.В., Кухарчук В.В., Сергиенко И.В., ид р. Нарушения липидного обмена. Клинические рекомендации 2023. Российский кардиологический журнал. 2023.28(5):5471. EDN: YVZOWJ. https://doi.org/10.15829/1560-4071-2023-5471

363. Mach F, Baigent C, Catapano AL et al. 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk.Eur Heart J. 2020;41:111-188. https://doi.org/10.1093/eurheartj/ehz455

364. Кухарчук В.В., Ежов М.В., Сергиенко И.В., и др. Клинические рекомендации Евразийской ассоциации кардиологов (ЕАК) / Национального общества по изучению атеросклероза (НОА) по диагностике и коррекции нарушений липидного обмена с целью профилактики и лечения атеросклероза (2020). Евразийский кардиологический журнал. 2020;(2):6-29. https://doi.org/10.38109/2225-1685-2020-2-6-29

365. Visseren FLJ, Mach F, Smulders YM et al. 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice Eur Heart J.2021;42:3227-3337. https://doi.org/10.1093/eurheartj/ehab484

366. Seidelmann SB, Claggett B, Cheng S et al. Dietary carbohydrate intake and mortality: a prospective cohort study and metaanalysis. Lancet Public Health. 2018 Sep;3(9):e419-e428. https://doi.org/10.1016/S2468-2667(18)30135-X

367. Dehghan M, Mente A, Rangarajan et al. Prospective Urban Rural Epidemiology (PURE) study investigators. Association of dairy intake with cardiovascular disease and mortality in 21 countries from five continents (PURE): a prospective cohort study. Lancet. 2018;392(10161):2288-2297. https://doi.org/110.1016/S0140-6736(18)31812-9

368. Arnett DK, Blumenthal RS, Albert MA et al. 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. 2019;140(11):e596-e646. https://doi.org/10.1161/CIR.0000000000000678

369. Carson JAS, Lichtenstein AH, Anderson CAM et al.; American Heart Association Nutrition Committee of the Council on Lifestyle and Cardiometabolic Health; Council on Arteriosclerosis, Thrombosis and Vascular Biology; Council on Cardiovascular and Stroke Nursing; Council on Clinical Cardiology; Council on Peripheral Vascular Disease; and Stroke Council. Dietary cholesterol and cardiovascular risk: a science advisory from the American Heart Association. Circulation.2020;141:e39–e53. https://doi.org/10.1161/CIR.0000000000000743

370. Weggemans RM, Zock PL, Katan MB. Dietary cholesterol from eggs increases the ratio of total cholesterol to high-density lipoprotein cholesterol in humans: a meta-analysis. Am J Clin Nutr. 2001;73(5):885-891. https://doi.org/10.1093/ajcn/73.5.885

371. Hopkins PN. Effects of dietary cholesterol on serum cholesterol: ameta-analysis and review. Am J Clin Nutr. 1992;55(6):1060-1070. https://doi.org/10.1093/ajcn/55.6.1060

372. Newby DE, Mannucci PM, Tell GS et al. Expert position paper on air pollution and cardiovascular disease. Eur Heart J. 2015;36(2):83-93b. https://doi.org/10.1093/eurheartj/ehu458

373. Estruch R, Ros E, Salas-Salvado J et al. Primary Prevention of Cardiovascular Disease with a Mediterranean Diet Supplemented with Extra-Virgin Olive Oil or Nuts. N Engl J Med. 2018;378(25):e34. https://doi.org/10.1056/NEJMoa1800389

374. Bach-Faig A, Geleva D, Carrasco J et al. Evaluating associations between Mediterranean diet adherence indexes and biomarkers of diet and disease. Public Health Nutr. 2006;9(8A):1110-7. https://doi.org/10.1017/S1368980007668499

375. de Lorgeril M, Salen P, Martin J-L et al. Mediterranean Diet, Traditional Risk Factors, and the Rate of Cardiovascular Complications After Myocardial Infarction. Circulation. 1999;99(6):779-785. https://doi.org/10.1161/01.cir.99.6.779

376. Willett W, Rockström J, Loken B et al. Food in the Anthropocene: the EAT-Lancet Commission on healthy diets from sustainable food systems. Lancet. 2019;393(10170):447-492. https://doi.org/10.1016/S0140-6736(18)31788-4

377. Moore TJ, Vollmer WM, Appel LJ et al. Effect of dietary patterns on ambulatory blood pressure: results from the Dietary Approaches to Stop Hypertension (DASH) Trial. DASH Collaborative Research Group. Hypertension. 1999;34(3):472-7. https://doi.org/10.1161/01.hyp.34.3.472

378. Mithril C, Dragsted LO, Meyer C et al. Guidelines for the New Nordic Diet. Public Health Nutr. 2012;15(10):1941-1947. https://doi.org/10.1017/S136898001100351X

379. Sacks FM, Lichtenstein AH, Wu JHY et al. American Heart Association. Dietary Fats and Cardiovascular Disease: A Presidential Advisory From the American Heart Association. Circulation. 2017;136(3):e1-e23. https://doi.org/10.1161/CIR.0000000000000510

380. Mensink RP, Zock PL, Kester AD et al. Effects of dietary fatty acids and carbohydrates on the ratio of serum total to HDL cholesterol and on serum lipids and apolipoproteins: a meta-analysis of 60 controlled trials. Am J Clin Nutr. 2003;77(5):1146-55. https://doi.org/10.1093/ajcn/77.5.1146

381. Bonanome A, Grundy SM. Effect of dietary stearic acid on plasma cholesterol and lipoprotein levels. N Engl J Med. 1988;318(19):1244-8. https://doi.org/10.1056/NEJM198805123181905

382. Mensink RP, Katan MB. Effect of dietary fatty acids on serum lipids and lipoproteins. A meta-analysis of 27 trials. Arterioscler Thromb. 1992;12(8):911-9. https://doi.org/10.1161/01.atv.12.8.911

383. Christensen JJ, Arnesen EK, Rundblad A. et al. Dietary fat quality, plasma atherogenic lipoproteins, and atherosclerotic cardiovascular disease: An overview of the rationale for dietary recommendations for fat intake. Atherosclerosis. 2024;389:117433. https://doi.org/10.1016/j.atherosclerosis.2023.117433

384. Mensink RP. Effects of saturated fatty acids on serum lipids and lipoproteins: a systematic review and regression analysis https://apps.who.int/iris/bitstream/handle/10665/246104/9789241565349-eng.pdf?sequence=1 (21 July 2020).

385. Eckel RH, Jakicic JM, Ard JD et al. American College of Cardiology/American Heart Association Task Force on Practice Guidelines. 2013 AHA/ACC guideline on lifestyle management to reduce cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 2014;129(25 Suppl 2):S76-99. https://doi.org/10.1161/01.cir.0000437740.48606.d1

386. Mozaffarian D, Katan MB, Ascherio A et al. Trans fatty acids and cardiovascular disease. N Engl J Med. 2006 Apr 13;354(15):1601-13. https://doi.org/10.1056/NEJMra054035

387. БойцовС. А., ПогосоваН. В., АншелесА. А., и др. Кардио-васкулярная профилактика 2022. Российские национальные рекомендации. Российский кардиологический журнал. 2023.28(5):5452. EDN: EUDWYG. https://doi.org/10.15829/1560-4071-2023-5452

388. Krogsbøll LT, Jørgensen KJ, Gøtzsche PC. General health checks in adults for reducing morbidity and mortality from disease. Cochrane Database Syst Rev. 2019;1(1):CD009009. CD009009. pub3. https://doi.org/10.1002/14651858

389. Zhong VW, Van Horn L, Greenland P et al. Associations of Processed Meat, Unprocessed Red Meat, Poultry, or Fish Intake With Incident Cardiovascular Disease and All-Cause Mortality. JAMA Intern Med. 2020;180(4):503-512. https://doi.org/10.1001/jamainternmed.2019.6969

390. Mach F, Baigent C, Catapano AL et al. 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk.Eur Heart J. 2020.41:111-188 https://doi.org/10.1093/eurheartj/ehz455

391. Chen M, Li Y, Sun Q et al. Dairy fat and risk of cardiovascular disease in 3 cohorts of US adults. Am J Clin Nutr. 2016;104(5):1209-1217. https://doi.org/10.3945/ajcn.116.134460

392. Jakobsen MU, O'Reilly EJ, Heitmann BL et al. Major types of dietary fat and risk of coronary heart disease: a pooled analysis of 11 cohort studies. Am J Clin Nutr. 2009;89(5):1425-32. https://doi.org/10.3945/ajcn.2008.27124

393. Mozaffarian D, Micha R, Wallace S. Effects on coronary heart disease of increasing polyunsaturated fat in place of saturated fat: a systematic review and meta-analysis of randomized controlled trials. PLoS Med. 2010;7(3):e1000252. https://doi.org/10.1371/journal.pmed.1000252

394. Wang DD, Li Y, Chiuve SE et al. Association of Specific Dietary Fats With Total and Cause-Specific Mortality. JAMA Intern Med. 2016;176(8):1134-45. https://doi.org/10.1001/jamainternmed.2016.2417

395. Mozaffarian D, Lemaitre RN, King IB et al. Plasma Phospholipid Long-Chain ω-3 Fatty Acids and Total and Cause-Specific Mortality in Older Adults. Ann Intern Med. 2013;158(7): 515-525. https://doi.org/10.7326/0003-4819-158-7-201304020-00003

396. Zheng J, Huang T, Yu Y et al. Fish consumption and CHD mortality: an updated meta-analysis of seventeen cohort studies. Public Health Nutr. 2012;15(4):725-37. https://doi.org/10.1017/S1368980011002254

397. Jacobson TA, Glickstein SB, Rowe JD et al. Effects of eicosapentaenoic acid and docosahexaenoic acid on low-density lipoprotein cholesterol and other lipids: a review. J Clin Lipidol. 2012;6(1):5-18. https://doi.org/10.1016/j.jacl.2011.10.018

398. World Health Organization. Guideline: sugars intake for adults and children. https://www.who.int/publications/i/item/9789241549028 (21 July 2020).

399. World Health Organization. A healthy diet sustainably produced. https://apps.who.int/iris/bitstream/handle/10665/278948/WHONMH-NHD-18.12-eng.pdf?ua=1 (21 July 2020).

400. Pelkman CL. Effects of the glycemic index of foods on serum concentrations of high-density lipoprotein cholesterol and triglycerides. Curr Atheroscler Rep. 2001;3(6):456-61. https://doi.org/10.1007/s11883-001-0035-6

401. Parks EJ, Hellerstein MK. Carbohydrate-induced hypertriacylglycerolemia: historical perspective and review of biological mechanisms. Am J Clin Nutr. 2000;71(2):412-33. https://doi.org/10.1093/ajcn/71.2.412

402. Halton TL, Willett WC, Liu S et al. Low-carbohydrate-diet score and the risk of coronary heart disease in women. N Engl J Med. 2006;355(19):1991-2002. https://doi.org/10.1056/NEJMoa055317

403. Jakobsen MU, Dethlefsen C, Joensen AM et al. Intake of carbohydrates compared with intake of saturated fatty acids and risk of myocardial infarction: importance of the glycemic index. Am J Clin Nutr. 2010;91(6):1764-8. https://doi.org/10.3945/ajcn.2009.29099

404. Taskinen MR, Söderlund S, Bogl LH et al. Adverse effects of fructose on cardiometabolic risk factors and hepatic lipid metabolism in subjects with abdominal obesity. J Intern Med. 2017;282(2):187-201. https://doi.org/10.1111/joim.12632

405. Stanhope KL, Schwarz JM, Keim NL et al. Consuming fructosesweetened, not glucose-sweetened, beverages increases visceral adiposity and lipids and decreases insulin sensitivity in overweight/obese humans. J Clin Invest. 2009;119(5):1322-34. https://doi.org/10.1172/JCI37385

406. Lawrence GD. Dietary Fats and Health: Dietary Recommendations in the Context of Scientific Evidence. Adv. Nutr. 2013;4: 294-302. https://doi.org/10.3945/an.113.003657

407. Brown L, Rosner B, Willett WW et al. Cholesterol-lowering effects of dietary fiber: a meta-analysis. Am J Clin Nutr. 1999;69(1):30-42. https://doi.org/10.1093/ajcn/69.1.30

408. Luo C, Zhang Y, Ding Y et al. Nut consumption and risk of type 2 diabetes, cardiovascular disease, and all-cause mortality: a systematic review and meta-analysis. Am J Clin Nutr. 2014;100(1):256-69. https://doi.org/10.3945/ajcn.113.076109

409. Тутельян В.А., Вялков А.И., Разумов А.Н. и соавт. Научные основы здорового питания; 2010; М.; Издательский дом «Панорама»; 816 с. ISBN: 978-5-86472-224-4

410. Threapleton DE, Greenwood DC, Evans CE et al. Dietary fiber intake and risk of cardiovascular disease: systematic review and meta-analysis. BMJ.2013.347:f6879. https://doi.org/10.1136/bmj.f6879

411. Crowe FL, Key TJ, Appleby PN et al. Dietary fibre intake and ischaemic heart disease mortality: the European Prospective Investigation into Cancer and Nutrition-Heart study. Eur J Clin Nutr. 2012;66(8):950-6. https://doi.org/10.1038/ejcn.2012.51

412. Wang DD, Li Y, Bhupathiraju SN et al. Fruit and Vegetable Intake and Mortality Results From 2 Prospective Cohort Studies of US Men and Women and a Meta-Analysis of 26 Cohort Studies. Circulation.2021.143:1642–1654. https://doi.org/10.1161/CIRCULATIONAHA.120.048996

413. Luo C, Zhang Y, Ding Y et al. Nut consumption and risk of type 2 diabetes, cardiovascular disease, and all-cause mortality: a systematic review and meta-analysis. Am J Clin Nutr. 2014;100(1):256-69. https://doi.org/10.3945/ajcn.113.076109

414. Wood AM, Kaptoge S, Butterworth AS et al. Emerging Risk Factors Collaboration/EPIC-CVD/UK Biobank Alcohol Study Group. Risk thresholds for alcohol consumption: combined analysis of individual-participant data for 599 912 current drinkers in 83 prospective studies. Lancet. 2018;391(10129):1513-1523. https://doi.org/10.1016/S0140-6736(18)30134-X

415. Sundfør TM, Svendsen M, Heggen E et al. BMI modifies the effect of dietary fat on atherogenic lipids: a randomized clinical trial. Am J Clin Nutr. 2019;110(4):832-841. https://doi.org/10.1093/ajcn/nqz113

416. Rippe J M, Angelopoulos TJ. Added sugars and risk factors for obesity, diabetes and heart disease. International Journal of Obesity. 2016;40:22-27. https://doi.org/10.1038/ijo.2016.10

417. Bays HE, Toth PP, Kris-Etherton PM et al. Obesity, adiposity, and dyslipidemia: a consensus statement from the National Lipid Association J Clin Lipidol. 2013;7(4):304-383. https://doi.org/10.1016/j.jacl.2013.04.001

418. Baumgartnera S, Bruckert E, Gallo A et al. The position of functional foods and supplements with a serum LDL-C lowering effect in the spectrum ranging from universal to care-related CVD risk management. Atherosclerosis. 2020;311:116-123. https://doi.org/10.1016/j.atherosclerosis.2020.07.019

419. Gylling H, Plat J, Turley S et al. European Atherosclerosis Society Consensus Panel on Phytosterols. Plant sterols and plant stanols in the management of dyslipidaemia and prevention of cardiovascular disease. Atherosclerosis. 2014;232(2):346-60. https://doi.org/10.1016/j.atherosclerosis.2013.11.043

420. Ras RT, Geleijnse JM, Trautwein EA. LDL-cholesterol-lowering effect of plant sterols and stanols across different dose ranges: a meta-analysis of randomised controlled studies. Br J Nutr. 2014;112(2):214-9. https://doi.org/10.1017/S0007114514000750

421. Musa-Veloso K, Poon TH, Elliot JA et al. A comparison of the LDL-cholesterol lowering efficacy of plant stanols and plant sterols over a continuous dose range: results of a meta-analysis of randomized, placebo-controlled trials. Prostaglandins Leukot Essent Fatty Acids. 2011;85(1):9-28. https://doi.org/10.1016/j.plefa.2011.02.001

422. Li Y, Jiang L, Jia Z et al. A Meta-Analysis of Red Yeast Rice: An Effective and Relatively Safe Alternative Approach for Dyslipidemia. PLoSOne. 2014;9(6):e98611. https://doi.org/10.1371/journal.pone.0098611

423. Lu Z, Kou W, Du B et al. Effect of Xuezhikang, an Extract From Red Yeast Chinese Rice, on Coronary Events in a Chinese Population With Previous Myocardial Infarction. Am J Cardiol. 2008;101(12):1689-1693. https://doi.org/10.1016/j.amjcard.2008.02.056

424. De Backer GG. Food supplements with red yeast rice: more regulations are needed. EurJPrevCardiol. 2017.24:1429-1430. https://doi.org/10.1177/2047487317716500

425. AbuMweis SS, Jew S, Ames NP. β-glucan from barley and its lipid-lowering capacity: a meta-analysis of randomized, controlled trials. EurJClinNutr. 2010;64(12):1472-1480. https://doi.org/10.1038/ejcn.2010.178

426. Ho HV, Sievenpiper JL, Zurbau A et al. The effect of oat β-glucan on LDL-cholesterol, non-HDL-cholesterol and apoB for CVD risk reduction: a systematic review and meta-analysis of randomisedcontrolled trials. Br J Nutr. 2016;116(8):1369-1382. https://doi.org/10.1017/S000711451600341X

427. Pirro M, Vetrani C, Bianchi C et al. Joint position statement on «Nutraceuticals for the treatment of hypercholesterolemia» of the Italian Society of Diabetology (SID) and of the Italian Society for the Study of Arteriosclerosis (SISA). Nutr Metab Cardiovasc Dis. 2017;27(1):2-17.https://doi.org/10.1016/j.numecd.2016.11.122

428. EFSA, Scientific Opinion on the substantiation of health claims related to pectins and reduction of post-prandial glycaemic responses 9ID 786), maintenance of normal blood cholesterol concentrations (ID 818), and increase in satiety leading to a reduction in energy intake (ID 4692) pursuant to Article 13(1) of Regulation (EC) No 1924/2006, Available online: https://efsa.onlinelibrary.wiley.com/doi/pdf/10.2903/j.efsa.2010.1747 (accessed on 29 April 2020).

429. Dewell A, Hollenbeck PL, Hollenbeck CB. Clinical review: a critical evaluation of the role of soy protein and isoflavone supplementation in the control of plasma cholesterol concentrations. J Clin Endocrinol Metab. 2006;91(3):772-80. https://doi.org/10.1210/jc.2004-2350

430. Kardalas E, Paschou SA, Anagnostis P, et al. Hypokalemia: a clinical update. Endocr Connect. 2018 Apr;7(4):R135-R146. https://doi.org/10.1530/EC-18-0109

431. Núñez J, Bayés-Genís A, Zannad F, et al. Long-Term Potassium Monitoring and Dynamics in Heart Failure and Risk of Mortality. Circulation. 2018 Mar 27;137(13):1320-1330. https://doi.org/10.1161/CIRCULATIONAHA.117.030576

432. Kashihara N, Kohsaka S, Kanda E, et al. Hyperkalemia in Real-World Patients Under Continuous Medical Care in Japan. Kidney Int Rep. 2019 May 30;4(9):1248-1260. https://doi.org/10.1016/j.ekir.2019.05.018

433. Trevisan M, Clase CM, Evans M, et al. Patterns of chronic and transient hyperkaliemia and clinically important outcomes in patients with chronic kidney disease. Clin Kidney J. 2021 Sep 4;15(1):153-161. https://doi.org/10.1093/ckj/sfab159

434. DuBose TD Jr. Regulation of Potassium Homeostasis in CKD. Adv Chronic Kidney Dis. 2017 Sep;24(5):305-314. https://doi.org/10.1053/j.ackd.2017.06.002

435. Collins AJ, Pitt B, Reaven N, et al. Association of Serum Potassium with All-Cause Mortality in Patients with and without Heart Failure, Chronic Kidney Disease, and/or Diabetes. Am J Nephrol. 2017;46(3):213-221. https://doi.org/10.1159/000479802

436. HYPERKALAEMIA GUIDELINE 2019 (ukkidney.org); Montford JR, Linas S. How Dangerous Is Hyperkalemia? J Am Soc Nephrol. 2017 Nov;28(11):3155-3165. https://doi.org/10.1681/ASN.2016121344

437. National Diet and Nutirtion Survey (NDNS) rolling program for 2014 to 2015 and 2015 to 2016 (results from Years 7 and 8 combined). www.gov.uk/government/statistics/ndns-resultsfrom-years7-and-8-combined

438. World Health Organisation (WHO). Guideline: Potassium Intake for Adults and Children; WHO: Geneva, Switzerland, 2012.

439. Cupisti, A., Kovesdy CP, D'Alessandro C et al. Dietary Approach to Recurrent or Chronic Hyperkalaemia in Patients with Decreased Kidney Function. Nutrients, 2018;10(3):261. https://doi.org/10.3390/nu10030261

440. Kalantar-Zadeh K. Nutritional Management of Chronic Kidney Disease. N Engl J Med, 2017;377(18):1765-1776. https://doi.org/10.1056/NEJMra1700312

441. Zhang Y, Chen P, Chen J, et al. Association of Low Serum Potassium Levels and Risk for All-Cause Mortality in Patients With Chronic Kidney Disease: A Systematic Review and Meta-Analysis. Ther Apher Dial. 2019 Feb;23(1):22-31. https://doi.org/10.1111/1744-9987.12753

442. Renal Association Clinical Practice Guideline – Undernutrition in Chronic Kidney Disease. June 2019. www.renal.org/wp-content/uploads/2019/06/FINAL-Nutirion-guideline-June-2019.pdf

443. Клинические рекомендации – Хроническая болезнь почек (ХБП) – 2021-2022-2023 (24.06.2021).

444. Morris A, Krishnan N, Kimani PK, et al. Effect of Dietary Potassium Restriction on Serum Potassium, Disease Progression, and Mortality in Chronic Kidney Disease: A Systematic Review and Meta-Analysis. J Ren Nutr. 2020 Jul;30(4):276-285. https://doi.org/10.1053/j.jrn.2019.09.009

445. Palmer BF, Clegg DJ. Treatment of Abnormalities of Potassium Homeostasis in CKD. Adv Chronic Kidney Dis. 2017 Sep;24(5):319-324. https://doi.org/10.1053/j.ackd.2017.06.001

446. Лукьянчиков В.С. Гипокалиемия. РМЖ. 2019;1(I):28–32.

447. Клинические Рекомендации Российской Ассоциации Эндокринологов. Гиперпаратиреоз. 2020; С-17.

448. Walker MD, Shane E. Hypercalcemia: A Review. JAMA. 2022 Oct 25;328(16):1624-1636. https://doi.org/10.1001/jama.2022.18331

449. Patnaik S, Lai YK. Just hypercalcaemia or acute ST elevation myocardial infarction? A review of hypercalcaemia-related electrocardiographic changes. BMJ Case Rep. 2015 Oct 21;2015:bcr2015211177. https://doi.org/10.1136/bcr-2015-211177

450. Shah AP, Lopez A, Wachsner RY, Meymandi SK, El-Bialy AK, Ichiuji AM. Sinus node dysfunction secondary to hyperparathyroidism. J Cardiovasc Pharmacol Ther. 2004 Jun;9(2):145-7. https://doi.org/10.1177/107424840400900209

451. Newman DB, Fidahussein SS, Kashiwagi DT, et al. Reversible cardiac dysfunction associated with hypocalcemia: a systematic review and meta-analysis of individual patient data. Heart Fail Rev. 2014 Mar;19(2):199-205. https://doi.org/10.1007/s10741-013-9371-1

452. Bilezikian J.P. et al. Hypoparathyroidism in the adult: epidemiology, diagnosis, pathophysiology, target-organ involvement, treatment, and challenges for future research. J. bone Miner. Res. Off. J. Am. Soc. Bone Miner. Res. 2011 Oct;26(10):2317-37. https://doi.org/10.1002/jbmr.483

453. Abdolmaleki M, Ohadi L, Maleki S. Dilated cardiomyopathy in patients with hypoparathyroidism: A narrative review. Health Sci Rep. 2024 Jan 4;7(1):e1796. https://doi.org/10.1002/hsr2.1796

454. Graczyk S, Grzeczka A, Pasławska U, et al. The Possible Influence of Vitamin D Levels on the Development of Atrial Fibrillation-An Update. Nutrients 2023 Jun 12;15(12):2725. https://doi.org/10.3390/nu15122725

455. Al Mheid I., Patel R.S., Tangpricha V., Quyyumi A.A. Vitamin D and cardiovascular disease: Is the evidence solid? Eur. Heart J. 2013 Dec;34(48):3691-3698. https://doi.org/10.1093/eurheartj/eht166

456. Hu Y.-F., Chen Y.-J., Lin Y.-J. et al. Inflammation and the pathogenesis of atrial fibrillation. Nat. Rev. Cardiol. 2015 Apr;12(4):230-243. https://doi.org/10.1038/nrcardio.2015.2

457. Rudolph V., Andrié R.P., Rudolph T.K. et al. Myeloperoxidase acts as a profibrotic mediator of atrial fibrillation. Nat. Med. 2010 Apr;16(4):470-474. https://doi.org/10.1038/nm.2124

458. Canning M.O., Grotenhuis K., De Wit H. et al. 1-alpha,25-Dihydroxyvitamin D3 (1,25(OH)(2)D(3)) hampers the maturation of fully active immature dendritic cells from monocytes. Eur. J. Endocrinol. 2001 Sep;145(3):351-357. https://doi.org/10.1530/eje.0.1450351

459. Hatzinikolaou-Kotsakou E., Tziakas D., Hotidis A. et al. Relation of C-Reactive Protein to the First Onset and the Recurrence Rate in Lone Atrial Fibrillation. Am. J. Cardiol. 2006 Mar 1;97(5):659-661. https://doi.org/10.1016/j.amjcard.2005.09.104

460. Shea M.K., Booth S.L., et al. Vitamin K and Vitamin D Status: Associations with Inflammatory Markers in the Framingham Offspring Study. Am. J. Epidemiol. 2008 Feb 1;167(3):313-320. https://doi.org/10.1093/aje/kwm306

461. Li Q., Dai Z., Cao Y., Wang L. Association of C-reactive protein and vitamin D deficiency with cardiovascular disease: A nationwide cross-sectional study from National Health and Nutrition Examination Survey 2007 to 2008. Clin. Cardiol. 2019 Jul;42(7):663-669. https://doi.org/10.1002/clc.23189

462. Ожирение. Клинические рекомендации Министерства Здравоохранения РФ. 2020г.-52 с.

463. World Health Organization. Obesity: preventing and managing the global epidemic. 1997, Geneva: WHO.

464. Campbell ET, Franks AT, Joseph PV. Adolescent obesity in the past decade: A systematic review of genetics and determinants of food choice. J Am Assoc Nurse Pract. 2019 Jun 5;31(6):344-351. https://doi.org/10.1097/JXX.0000000000000154

465. Knowler WC, Barrett-Connor E, Fowler SE, et al. Diabetes Prevention Program Research Group: Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002;346:393-403. https://doi.org/10.1056/NEJMoa012512

466. World Health Organization: Obesity: Preventing and Managing the Global Epidemic. Report of a WHO Consultation (WHO Technical Report Series 894). Geneva, WHO, 1998. www.who.int/nutrition/publications/obesity/WHO_TRS_894/en/ (last accessed November 30, 2015).

467. Cefalu WT, Bray GA, Home PD, et al. Advances in the science, treatment, and prevention of the disease of obesity: reflections from a Diabetes Care editors’ expert forum. Diabetes Care. 2015;38(8):1567-1582. https://doi.org/10.2337/dc15-1081

468. American Association of Clinical Endocrinologists and American College of Endocrinology Comprehensive Clinical Practice Guidelines for Medical Care of Patients with Obesity. Endocr Pract. 2016 Jul:22 Suppl 3:1-203. https://doi.org/10.4158/ep161365.gl

469. Нутрициология и клиническая диетология: Национальное руководство / под ред. В.А.Тутельяна, Д.Б. Никитюка. – Москва: ГЭОТАР-Медиа, 2020. - 656 с.: ил. – (Серия «Национальные руководства»). ISBN: 978-5-9704-5352-0. https://doi.org/10.33029/9704-5352-0-NKD-2020-1-656

470. Nutrition and Clinical Dietetics: National Guidelines / edited by V.A. Tutelyan, D.B. Nikityuk. – Moscow: GEOTAR-Media, 2020. -656 s: ill. – (Series «National Guidelines»). ISBN: 978-5-9704-5352-0. https://doi.org/10.33029/9704-5352-0-NKD-2020-1-656

471. Shai I, Schwarzfuchs D, Henkin Y, et al., for the Dietary Intervention Randomized Controlled Trial (DIRECT) Group. Weight loss with a low-carbohydrate, Mediterranean, or low-fat diet. N Engl J Med 2008;359:229-241. https://doi.org/10.1056/NEJMoa0708681

472. Estruch R, Ros E, Salas-Salvadó J, et al., PREDIMED Study Investigators. Primary Prevention of Cardiovascular Disease with a Mediterranean Diet Supplemented with Extra-Virgin Olive Oil or Nuts. N Engl J Med. 2018 Jun 21;378(25):e34. Epub 2018 Jun 13. PMID: 29897866. https://doi.org/10.1056/nejmoa1800389

473. Avenell A., Brown T., McGee M. et al. What are the long-term benefits of weight reducing diets in adults? A systematic review of randomized controlled trials. J Hum Nutr Diet 2004;17:317-35. https://doi.org/10.1111/j.1365-277X.2004.00531.x

474. Dansinger M.L., Gleason J.A., Griffith J.L. et al. Comparison of the Atkins, Ornish, Weight Watchers, and Zone Diets for Weight Loss and Heart Disease Risk ReductionA Randomized Trial. JAMA. 2005;293(1):43-53. https://doi.org/10.1001/jama.293.1.43

475. Wharton S, Lau DCW, Vallis M et al. GUIDELINE. Obesity in adults: a clinical practice guideline. Cite as: CMAJ 2020 August 4;192:E875-91. https://doi.org/10.1503/cmaj.191707

476. Mayer SB, Graybill S, Raffa SD, et al. Synopsis of the 2020 U.S. VA/DoD Clinical Practice Guideline for the Management of Adult Overweight and Obesity. Mil Med. 2021 Aug 28;186(9-10):884-896. https://doi.org/10.1093/milmed/usab114

477. Hassapidou M, Vlassopoulos A, Kalliostra M, et al. European Association for the Study of Obesity Position Statement on Medical Nutrition Therapy for the Management of Overweight and Obesity in Adults Developed in Collaboration with the European Federation of the Associations of Dietitians. Obes Facts. 2023;16(1):11-28. https://doi.org/10.1159/000528083

478. Willis LH, Slentz CA, Bateman LA, et al. Effects of aerobic and/or resistance training on body mass and fat mass in overweight or obese adults. J Appl Physiol (1985). 2012 Dec 15;113(12):1831-7. https://doi.org/10.1152/japplphysiol.01370.2011

479. Geliebter A, Christopher N, Ochner CN, et al. Obesity-related hormones and metabolic risk factors: a randomized trial of diet plus either strength or aerobic training versus diet alone in overweight participants. J Diabetes Obes 2015;1:1-7. PMID: 25599089 PMCID: PMC4293637

480. Chin SH, Kahathuduwa CN, Binks M. Physical activity and obesity: what we know and what we need to know. Obes Rev. 2016 Dec;17(12):1226-1244. https://doi.org/10.1111/obr.12460

481. Stephens S.K., Cobiac L.J., Lennert Veerman. J. Improving diet and physical activity to reduce population prevalence of overweight and obesity: An overview of current evidence. Preventive Medicine. 2014 May;62:167-78. https://doi.org/10.1016/j.ypmed.2014.02.008

482. Нормы физиологических потребностей в энергии и пищевых веществах для различных групп населения Российской Федерации: Методические рекомендации. — М.: Федеральная служба по надзору в сфере защиты прав потребителей и благополучия человека, 2021. — 72 с.

483. Дедов И.И., Шестакова М.В., Майоров А.Ю., и соавт. Алгоритмы специализированной медицинской помощи больным сахарным диабетом / Под редакцией И.И. Дедова, М.В. Шестаковой, А.Ю. Майорова. 11-й выпуск. Сахарный диабет. 2023;26(2S):1-157. https://doi.org/10.14341/DM13042

484. Marx N, Federici M, Schütt K, et al.; ESC Scientific Document Group. 2023 ESC Guidelines for the management of cardiovascular disease in patients with diabetes. Eur Heart J. 2023 Oct 14;44(39):4043-4140. https://doi.org/10.1093/eurheartj/ehad192

485. Степанченко О.А., Баринов Е.Х., Хохлова Т.Ю., Горбачев А.В. Основные причины смертности у лиц с сахарным диабетом. Факторы риска и клинические ошибки. Здравоохранение Югры: опыт и инновации 2022;3(32):43-55.

486. Бойцов С.А., Погосова Н.В., Аншелес А.А., и др. Кардиоваскулярная профилактика 2022. Российские национальные рекомендации. Российский кардиологический журнал. 2023;28(5):5452. https://doi.org/10.15829/1560-4071-2023-5452

487. Дедов И.И., Шестакова М.В., Викулова О.К., и др. Сахарный диабет в Российской Федерации: динамика эпидемиологических показателей по данным Федерального регистра сахарного диабета за период 2010-2022 гг. Сахарный диабет. 2023;26(2):104-123. https://doi.org/10.14341/DM13035

488. Mahmood S.S., Levy D., Vasan R.S., Wang T.J. The Framingham Heart Study and the epidemiology of cardiovascular disease: a historical perspective. Lancet. 2014;383(9921):999-1008. https://doi.org/10.1016/S0140-6736(13)61752-3

489. Анциферов М.Б., Кобалава Ж.Д., Демидова Т.Ю., и др. Оценка распространенности хронической сердечной недостаточности у пациентов с сахарным диабетом 2 типа, госпитализированных в многопрофильные стационары: результаты проспективного наблюдательного многоцентрового исследования (КРЕДО). Сахарный диабет. 2024;27(1):4-14. https://doi.org/10.14341/DM13124

490. Jia G, Sowers JR. Hypertension in Diabetes: An Update of Basic Mechanisms and Clinical Disease. Hypertension. 2021 Nov; 78(5):1197-1205. https://doi.org/10.1161/HYPERTENSIONAHA.121.17981

491. Гороховская Г.Н., Юн В.Л., Васюк Ю.А., и др. Взаимосвязь сахарного диабета 2-го типа и сердечно-сосудистой патологии: значение контроля гликемии на пути решения проблемы. Медицинский совет. 2020;(4):22-28. https://doi.org/10.21518/2079-701X-2020-4-22-28

492. Анциферов М.Б. Результаты UKPDS и их значение в совершенствовании специализированной помощи больным диабетом. Сахарный диабет. 1999;2(4):23-28. https://doi.org/10.14341/2072-0351-6129

493. Остроумова О.Д., Голобородова И.В., Фомина В.М. Сердечно-сосудистые риски у больных сахарным диабетом 2 типа/ Кардиоваскулярная терапия и профилактика. 2018;17(4):81-94. https://doi.org/10.15829/1728-8800-2018-4-81-94

494. Look AHEAD Research Group; Wing RR, Bolin P, Brancati FL, et al. Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes. N Engl J Med. 2013 Jul 11;369(2):145-54. https://doi.org/10.1056/NEJMoa1212914

495. Visseren FLJ, Mach F, Smulders YM, et al.; ESC Scientific Document Group. 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice: Developed by the Task Force for cardiovascular disease prevention in clinical practice with representatives of the European Society of Cardiology and 12 medical societies With the special contribution of the European Association of Preventive Cardiology (EAPC). Rev Esp Cardiol (Engl Ed). 2022 May;75(5):429. English, Spanish. https://doi.org/10.1016/j.rec.2022.04.003

496. Kim J, Hur M-H. The effects of dietary education interventions on individuals with type 2 diabetes: a systematic review and metaanalysis. Int J Environ Res Public Health. 2021;18:8439. https://doi.org/10.3390/ijerph18168439

497. Diabetes and Nutrition Study Group (DNSG) of the European Association for the Study of Diabetes (EASD). Evidence-based European recommendations for the dietary management of diabetes. Diabetologia. 2023 Jun;66(6):965-985. https://doi.org/10.1007/s00125-023-05894-8

498. Khan TA, Field D, Chen V, et al. Combination of Multiple Low-Risk Lifestyle Behaviors and Incident Type 2 Diabetes: A Systematic Review and Dose-Response Meta-analysis of Prospective Cohort Studies. Diabetes Care. 2023 Mar 1;46(3):643-656. https://doi.org/10.2337/dc22-1024

499. Massara P, Viguiliouk E, Glenn A et al. Nordic dietary pattern and cardiometabolic outcomes: a systematic review and metaanalysis of prospective cohort studies and randomized controlled trials. Curr Dev Nutr. 2020; 4(Supplement_2):546–546.

500. Reynolds A, Mann J, Cummings J, et al. Carbohydrate quality and human health: a series of systematic reviews and meta-analyses. Lancet. 2019 Feb 2;393(10170):434-445. https://doi.org/10.1016/S0140-6736(18)31809-9

501. Livesey G, Taylor R, Livesey HF, et al. Dietary Glycemic Index and Load and the Risk of Type 2 Diabetes: A Systematic Review and Updated Meta-Analyses of Prospective Cohort Studies. Nutrients. 2019 Jun 5;11(6):1280. https://doi.org/10.3390/nu11061280

502. Aro A, Kauppinen A, Kivinen N, et al. Life Style Intervention Improves Retinopathy Status-The Finnish Diabetes Prevention Study. Nutrients. 2019 Jul 23;11(7):1691. https://doi.org/10.3390/nu11071691

503. Galaviz KI, Weber MB, Straus A, et al. Global Diabetes Prevention Interventions: A Systematic Review and Network Metaanalysis of the Real-World Impact on Incidence, Weight, and Glucose. Diabetes Care. 2018 Jul;41(7):1526-1534. https://doi.org/10.2337/dc17-2222

504. American Diabetes Association. Standards of Care in Diabetes 2024. https://doi.org/10.2337/dc24-S005

505. Ikramuddin S, Korner J, Lee WJ, et al. Lifestyle Intervention and Medical Management With vs Without Roux-en-Y Gastric Bypass and Control of Hemoglobin A1c, LDL Cholesterol, and Systolic Blood Pressure at 5 Years in the Diabetes Surgery Study. JAMA. 2018 Jan 16;319(3):266-278. https://doi.org/10.1001/jama.2017.20813

506. Doumouras AG, Wong JA, Paterson JM, et al. Bariatric Surgery and Cardiovascular Outcomes in Patients With Obesity and Cardiovascular Disease: A Population-Based Retrospective Cohort Study. Circulation. 2021 Apr 13;143(15):1468-1480. https://doi.org/10.1161/CIRCULATIONAHA.120.052386

507. Stancoven A, McGuire DK. Preventing macrovascular complications in type 2 diabetes mellitus: glucose control and beyond. Am J Cardiol. 2007 Jun 4;99(11A):5H-11H. https://doi.org/10.1016/j.amjcard.2007.04.005

508. Look AHEAD Research Group; Gregg EW, Jakicic JM, Blackburn G, et al. Association of the magnitude of weight loss and changes in physical fitness with long-term cardiovascular disease outcomes in overweight or obese people with type 2 diabetes: a post-hoc analysis of the Look AHEAD randomised clinical trial. Lancet Diabetes Endocrinol. 2016 Nov;4(11):913-921. https://doi.org/10.1016/S2213-8587(16)30162-0

509. Lean ME, Leslie WS, Barnes AC, et al. Primary care-led weight management for remission of type 2 diabetes (DiRECT): an openlabel, cluster-randomised trial. Lancet. 2018 Feb 10;391(10120):541-551. https://doi.org/10.1016/S0140-6736(17)33102-1

510. Lean MEJ, Leslie WS, Barnes AC, et al. Durability of a primary care-led weight-management intervention for remission of type 2 diabetes: 2-year results of the DiRECT open-label, clusterrandomised trial. Lancet Diabetes Endocrinol. 2019 May;7(5):344-355. https://doi.org/10.1016/S2213-8587(19)30068-3

511. Steven S, Hollingsworth KG, Al-Mrabeh A, Avery L, Aribisala B, Caslake M, Taylor R. Very Low-Calorie Diet and 6 Months of Weight Stability in Type 2 Diabetes: Pathophysiological Changes in Responders and Nonresponders. Diabetes Care. 2016 May;39(5):808-15. https://doi.org/10.2337/dc15-1942

512. He FJ, Tan M, Ma Y, MacGregor GA. Salt Reduction to Prevent Hypertension and Cardiovascular Disease: JACC State-of-the-Art Review. J Am Coll Cardiol. 2020 Feb 18;75(6):632-647. https://doi.org/10.1016/j.jacc.2019.11.055

513. Sluik D, Buijsse B, Muckelbauer R, et al. Physical Activity and Mortality in Individuals With Diabetes Mellitus: A Prospective Study and Meta-analysis. Arch Intern Med. 2012 Sep 24;172(17):1285-95. https://doi.org/10.1001/archinternmed.2012.3130

514. Wahid A, Manek N, Nichols M, et al. Quantifying the Association Between Physical Activity and Cardiovascular Disease and Diabetes: A Systematic Review and Meta-Analysis. J Am Heart Assoc. 2016 Sep 14;5(9):e002495. https://doi.org/10.1161/JAHA.115.002495

515. Church TS, Blair SN, Cocreham S, et al. Effects of aerobic and resistance training on hemoglobin A1c levels in patients with type 2 diabetes: a randomized controlled trial. JAMA. 2010 Nov 24;304(20):2253-62. https://doi.org/10.1001/jama.2010.1710

516. Hansen D, Abreu A, Ambrosetti M, et al. Exercise intensity assessment and prescription in cardiovascular rehabilitation and beyond: why and how: a position statement from the Secondary Prevention and Rehabilitation Section of the European Association of Preventive Cardiology. Eur J Prev Cardiol. 2022 Feb 19;29(1):230-245. https://doi.org/10.1093/eurjpc/zwab007

517. Kemps H, Kränkel N, Dörr M, et al. Exercise training for patients with type 2 diabetes and cardiovascular disease: What to pursue and how to do it. A Position Paper of the European Association of Preventive Cardiology (EAPC). Eur J Prev Cardiol. 2019 May;26(7):709-727. https://doi.org/10.1177/2047487318820420

518. Hansen D, Abreu A, Ambrosetti M, et al. Exercise intensity assessment and prescription in cardiovascular rehabilitation and beyond: why and how: a position statement from the Secondary Prevention and Rehabilitation Section of the European Association of Preventive Cardiology. Eur J Prev Cardiol. 2022 Feb 19;29(1):230-245. https://doi.org/10.1093/eurjpc/zwab007

519. Churuangsuk CHJ, Reynolds A, Griffin S, Combet E, Lean M. Diets for weight management in adults with type 2 diabetes: an umbrella review of published meta-analyses and systematic review of trials of diets for diabetes remission. Diabetologia. 2022;65(1):14-36. https://doi.org/10.1007/s00125-021-05577-2

520. Noronha JC, Nishi SK, Braunstein CR et al. The effect of liquid meal replacements on cardiometabolic risk factors in overweight / obese individuals with type 2 diabetes: a systematic review and meta-analysis of randomized controlled trials. Diabetes Care. 2022;42(5):767-776. https://doi.org/10.2337/dc18-2270

521. Sacks FM, Lichtenstein AH, Wu JH, et al. Dietary fats and cardiovascular disease: a presidential advisory from the American Heart Association. Circulation 2017;136:e1-e23. https://doi.org/10.1161/CIR.0000000000000510

522. Estruch R, Ros E, Salas-Salvadó J, et al. Primary prevention of cardiovascular disease with a Mediterranean diet supplemented with extra-virgin olive oil or nuts. N Engl J Med 2018;378:e34. https://doi.org/10.1056/NEJMoa1800389

523. Qian F, Liu G, Hu FB, et al. Association between plant-based dietary patterns and risk of type 2 diabetes: a systematic review and meta-analysis. JAMA Intern Med 2019;179:1335-1344. https://doi.org/10.1001/jamainternmed.2019.2195

524. Willett W, Rockström J, Loken B, et al. Food in the Anthropocene: the EAT–Lancet Commission on healthy diets from sustainable food systems. Lancet 2019;393:447-492. https://doi.org/10.1016/S0140-6736(18)31788-4

525. Delgado-Lista J, Alcala-Diaz JF, Torres-Peña JD, et al. Longterm secondary prevention of cardiovascular disease with a Mediterranean diet and a low-fat diet (CORDIOPREV): a randomised controlled trial. Lancet 2022;399:1876-1885. https://doi.org/10.1016/S0140-6736(22)00122-2

526. Esposito K., Maiorino M.I., Bellastella G., et al. A journey into a Mediterraneandiet and type 2 diabetes: A systematic review with meta-analyses. BMJ Open 2015;5:e008222. https://doi.org/10.1136/bmjopen-2015-008222

527. Panagiotakos D.B., Tzima N., Pitsavos C., et al. The association between adherence to the Mediterraneandiet and fasting indices of glucose homoeostasis: The Attica study. J. Am. Coll. Nutr. 2007;26:32-38. https://doi.org/10.1080/07315724.2007.10719583

528. Daneshzad E, Emami S, Darooghegi Mofrad M, et al. Association of modified Nordic diet with cardiovascular risk factors among type 2 diabetes patients: a cross-sectional study. J Cardiovasc Thorac Res. 2018;10(3):153-161. https://doi.org/10.15171/jcvtr.2018.25

529. Mu L, Yu P, Xu H, et al. Effect of sodium reduction based on the DASH diet on blood pressure in hypertensive patients with type 2 diabetes. Nutr Hosp. 2022 Jun 24;39(3):537-546. https://doi.org/10.20960/nh.04039

530. Paula TP, Viana LV, Neto AT, et al. Effects of the DASH Diet and Walking on Blood Pressure in Patients With Type 2 Diabetes and Uncontrolled Hypertension: A Randomized Controlled Trial. J Clin Hypertens (Greenwich). 2015 Nov;17(11):895-901. https://doi.org/10.1111/jch.12597

531. Wickman BE, Enkhmaa B, Ridberg R, et al. Dietary Management of Heart Failure: DASH Diet and Precision Nutrition Perspectives. Nutrients. 2021 Dec 10;13(12):4424. https://doi.org/10.3390/nu13124424

532. Chiavaroli L, Viguiliouk E, Nishi SK et al. DASH dietary pattern and cardiometabolic outcomes: an umbrella review of systematic reviews and meta-analyses. Nutrients. 2019;11(2):338. https://doi.org/10.3390/nu11020338

533. Glenn AJ, Li J, Lo K, et al. The Portfolio Diet and Incident Type 2 Diabetes: Findings From the Women's Health Initiative Prospective Cohort Study. Diabetes Care. 2023 Jan 1;46(1):28-37. https://doi.org/10.2337/dc22-1029

534. Churuangsuk C, Griffiths D, Lean MEJ, Combet E. Impacts of carbohydrate-restricted diets on micronutrient intakes and status: A systematic review. Obes Rev. 2019;20(8):1132-1147. https://doi.org/10.1111/obr.12857

535. Spoke C, Malaeb S. A case of hypoglycemia associated with the ketogenic diet and alcohol use. J Endocr Soc. 2020;4(6):bvaa045. https://doi.org/10.1210/jendso/bvaa045

536. Charoensri S, Sothornwit J, Trirattanapikul A, Pongchaiyakul C. Ketogenic diet-induced diabetic ketoacidosis in a young adult with unrecognized type 1 diabetes. Case Rep Endocrinol 2021:6620832. https://doi.org/10.1155/2021/6620832

537. Marzban S, Arbee M, Vorajee N, Richards GA. Non-diabetic ketoacidosis associated with a low carbohydrate, high fat diet in a postpartum lactating female. Oxf Med Case Rep. 2020(8):omz026. https://doi.org/10.1093/omcr/omz026

538. Iizuka K, Yabe D. Dietary and Nutritional Guidelines for People with Diabetes. Nutrients. 2023 Oct 10;15(20):4314. https://doi.org/10.3390/nu15204314

539. Chiavaroli L, Lee D, Ahmed A et al. Effect of low glycaemic index or load dietary patterns on glycaemic control and cardiometabolic risk factors in diabetes: systematic review and meta-analysis of randomised controlled trials. BMJ. 2021;374:n1651. https://doi.org/10.1136/bmj.n1651

540. Atkinson FS, Brand-Miller JC, Foster-Powell K, et al. International tables of glycemic index and glycemic load values 2021: a systematic review. Am J Clin Nutr. 2021 Nov 8;114(5):1625-1632. https://doi.org/10.1093/ajcn/nqab233

541. Livesey G, Taylor R, Livesey HF et al. Dietary glycemic index and load and the risk of type 2 diabetes: a systematic review and updated meta-analyses of prospective cohort studies. Nutrients. 2019;11(6):1280. https://doi.org/10.3390/nu11061280

542. Reynolds A, Mitri J. Dietary Advice For Individuals with Diabetes. [Updated 2024 Apr 28]. In: Feingold KR, Anawalt B, Blackman MR, et al., editors. Endotext [Internet]. South Dartmouth (MA): MDText.com, Inc.; 2000-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK279012

543. Vaz EC, Porfírio GJM, Nunes HRDC, Nunes-Nogueira VDS. Effectiveness and safety of carbohydrate counting in the management of adult patients with type 1 diabetes mellitus: a systematic review and meta-analysis. Arch Endocrinol Metab. 2018;62(3):337-345. https://doi.org/10.20945/2359-3997000000045

544. Reynolds AN, Akerman AP, Mann J. Dietary fibre and whole grains in diabetes management: Systematic review and meta-analyses. PLoS Med. 2020;17(3):e1003053. https://doi.org/10.1371/journal.pmed.1003053

545. Reynolds A, Mann J, Cummings J, et al. Carbohydrate quality and human health: a series of systematic reviews and meta-analyses. Lancet. 2019;393(10170):434–445. https://doi.org/10.1016/S0140-6736(18)31809-9

546. Нормы физиологических потребностей в энергии и пищевых веществах для различных групп населения Российской Федерации: Методические рекомендации МР 2.3.1.0253—21. — М.: Федеральная служба по надзору в сфере защиты прав потребителей и благополучия человека, 2021. — 72 с.

547. Руководство по потреблению сахаров взрослыми и детьми. ВОЗ, 2015.

548. McGlynn ND, Khan TA, Wang L et al. Association of low-and nocalorie sweetened beverages as a replacement for sugar-sweetened beverages with body weight and cardiometabolic risk: a systematic review and meta-analysis. JAMA Netw Open. 2022;5(3):e222092. https://doi.org/10.1001/jamanetworkopen.2022.2092

549. Lee JJ, Khan TA, McGlynn N et al. Relation of change or substitution of low-and no-calorie sweetened beverages with cardiometabolic outcomes: a systematic review and meta-analysis of prospective cohort studies. Diabetes Care. 2022;45(8):1917-1930. https://doi.org/10.2337/dc21-2130

550. Lohner S, Kuellenberg de Gaudry D, Toews I, et al. Non-nutritive sweeteners for diabetes mellitus. Cochrane Database Syst Rev. 2020 May 25;5(5):CD012885. https://doi.org/10.1002/14651858.CD012885.pub2

551. Schwab U, Reynolds AN, Sallinen T, et al. Dietary fat intakes and cardiovascular disease risk in adults with type 2 diabetes: a systematic review and meta-analysis. Eur J Nutr. 2021;60(6):3355-3363. https://doi.org/10.1007/s00394-021-02507-1

552. Hooper L, Martin N, Jimoh OF, et al. Reduction in saturated fat intake for cardiovascular disease. Cochrane Database Syst Rev. 2020; Issue 8, Art. no.: CD011737. https://doi.org/10.1002/14651858.CD011737.pub3

553. Reynolds A, Hodson L, de Souza R, et al. Saturated fat and transfat intakes and their replacement with other macronutrients: a systematic review and meta-analysis of prospective observational studies. World Health Organization, Geneva. 2023.

554. Wang S, Tian W, Liu Y et al. Temporal trend of circulating transfatty acids and risk of long-term mortality in general population. Clin Nutr. 2021;40(3):1095-1101. https://doi.org/10.1016/j.clnu.2020.07.010

555. Schwab U, Reynolds AN, Sallinen T, et al. Dietary fat intakes and cardiovascular disease risk in adults with type 2 diabetes: a systematic review and meta-analysis. Eur J Nutr. 2021;60(6):3355-3363. https://doi.org/10.1007/s00394-021-02507-1

556. Bauer J, Biolo G, Cederholm T et al. Evidence-based recommendations for optimal dietary protein intake in older people: a position paper from the PROT-AGE Study Group. J Am Med Dir Assoc. 2013;14(8):542-559. https://doi.org/10.1016/j.jamda.2013.05.021

557. Pfeiffer AFH, Pedersen E, Schwab U et al. The effects of different quantities and qualities of protein intake in people with diabetes mellitus. Nutrients. 2020;12(2):365. https://doi.org/10.3390/nu12020365

558. Lean ME, Leslie WS, Barnes AC et al. Primary care-led weight management for remission of type 2 diabetes (DiRECT): an openlabel, cluster-randomised trial. Lancet. 2018;391(10120):541-551. https://doi.org/10.1016/S0140-6736(17)33102-1

559. Pratama S, Lauren BC, Wisnu W. The efficacy of vitamin B12 supplementation for treating vitamin B12 deficiency and peripheral neuropathy in metformin-treated type 2 diabetes mellitus patients: A systematic review. Diabetes Metab Syndr. 2022 Oct;16(10):102634. https://doi.org/10.1016/j.dsx.2022.102634

560. Oba-Yamamoto C., Takeuchi J., Nakamura A. et al. Combination of alcohol and glucose consumption as a risk to induce reactive hypoglycemia. Journal of Diabetes Investigation. 2021;12(4):651-657. https://doi.org/10.1111/jdi.13375

561. Choi HK, McCormick N, Yokose C. Excess comorbidities in gout: the causal paradigm and pleiotropic approaches to care. Nat Rev Rheumatol. 2022;18(2):97–111. https://doi.org/10.1038/s41584-021-00725-9

562. Richette P., Bardin T. Gout. Lancet 2010;375(9711):318–28. https://doi.org/10.1016/S0140-6736(09)60883-7

563. Громова М.А., Цурко В.В., Мелехина А.С. Рационально-обоснованный подход к питанию у больных подагрой. Клиницист. 2019;13(3-4):15-21. https://doi.org/10.17650/1818-8338-2019-13-3-4-15-21

564. Richette P, Doherty M, Pascual E, et al. 2016 updated EULAR evidence-based recommendations for the management of gout. AnnRheumDis. 2017;76:29-42. https://doi.org/10.1136/annrheumdis-2016-209707

565. Sivera F, Andrés M, Carmona L, et al. Multinational evidencebasedrecommendations for thediagnosisandmanagement of gout: integrating systematic literature review and expert opinion of a broad panel of rheumatologists in the 3e initiative. Ann Rheum Dis. 2014;73:328-35. https://doi.org/10.1136/annrheumdis-2013-203325

566. Mattiuzzi C, Lippi G. Recent updates on worldwide gout epidemiology. ClinRheumatol. 2020;39:1061-3. https://doi.org/10.1007/s10067-019-04868-9

567. Драпкина О. М., Мазуров В. И., Мартынов А. И., и соавт. Консенсус для врачей поведению пациентов с бессимптомной гиперурикемией в общетерапевтической практике. Кардиоваскулярная терапия и профилактика.2024;23(1):3737. https://doi.org/10.15829/1728-8800-2024-3737

568. Borghi С., Domienik-Karłowicz J., Tykarski A et. al. Expert consensus for the diagnosis and treatment of patient with hyperuricemia and high cardiovascular risk: 2021 update. Cardiology Journal. 2021;28(1):1-14. https://doi.org/10.5603/CJ.a2021.0001

569. Чазова И.Е., Жернакова Ю.В., Кисляк О.А., Подзолков В.И., Ощепкова Е.В., Миронова О.Ю., Блинова Н.В. Консенсус по ведению пациентов с гиперурикемией и высоким сердечно-сосудистым риском: 2022. Системные гипертензии. 2022;19(1):5-22. https://doi.org/10.38109/2075-082X-2022-1-5-22

570. ESC Clinical Practice Guidelines: Policies and Procedures. https://www.escardio.org/Guidelines/Clinical-Practice-Guidelines/Guidelines-development/Writing-ESC-Guidelines. December2022

571. OxfordCentreforEvidence-BasedMedicine. OCEBMlevels of evidence. 2022. https://www.cebm.ox.ac.uk/resources/levels-ofevidence/ocebm-levels-of-evidence. Last access: 06.01.2022

572. Nielsen S.M., Zobbe K., Kristensen L.E., Christensen R.Nutritional recommendations for gout: An update from clinical epidemiology. AutoimmunRev. 2018;17(11):1090-6. https://doi.org/10.1016/j.autrev.2018.05.008

573. Sautner J, Eichbauer-Sturm G, Gruber J et al. 2022 update of the Austrian Society of Rheumatology and Rehabilitation nutrition and lifestyle recommendations for patients with gout and hyperuricemia. Wien Klin Wochenschr. 2022 Jul;134(13-14):546-554. https://doi.org/10.1007/s00508-022-02054-7

574. Juraschek SP, Miller ER III, Gelber AC. Body mass index, obesity, and prevalent gout in the United States in 1988–1994 and 2007–2010. Arthritis Care Res (Hoboken). 2013;65(1):127-32. https://doi.org/10.1002/acr.21791

575. McCormick N,Rai SK, Lu N, Yokose C et al. Estimation of primary prevention of gout in men through Modification of obesity and other key lifestyle factors. JAMA NetwOpen. 2020;3(11):e2027421. https://doi.org/10.1001/jamanetworkopen.2020.27421

576. Zhu Y, Zhang Y, Choi HK. The serum urate-lowering impact of weight loss among men with a high cardiovascular risk profile: the multiple risk factor intervention trial. Rheumatology(Oxford). 2010;49(12):2391-9. https://doi.org/10.1093/rheumatology/keq256

577. Чазова И.Е., Жернакова Ю.В. от имени экспертов. Клинические рекомендации. Диагностика и лечение артериальной гипертонии. Системные гипертензии. 2019;16(1):6-31. https://doi.org/10.26442/2075082X.2019.1.190179

578. Mancia G, Kreutz R, Brunström M, et al. 2023 ESH Guidelines for the management of arterial hypertension The Task Force for the management of arterial hypertension of the European Society of Hypertension: Endorsed by the International Society of Hypertension (ISH) and the European Renal Association (ERA). J Hypertens. 2023;41(12):1874-2071. https://doi.org/10.1097/HJH.0000000000003480

579. U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Heart, Lung, and Blood Institute Your Guide to Lowering Your Blood Pressure with DASH https://www.nhlbi.nih.gov/files/docs/public/heart/new_dash.pdf

580. Tang O, Miller ER 3rd, Gelber AC et al. DASH diet and change in serum uric acid over time. ClinRheumatol. 2017;36(6):1413-7. https://doi.org/10.1007/s10067-017-3613-x

581. Gao Y, Cui LF, Sun YY, et al. Adherence to the dietary approaches to stop hypertension diet and hyperuricemia: a cross-sectional study. Arthritis Care Res (Hoboken). 2021;73(4):603-11. https://doi.org/10.1002/acr.24150

582. Choi H.K., Atkinson K., Karlson E.W.et al. Purine-rich foods, dairy and protein intake, and the risk of gout in men. N Engl J Med2004; 350(11):1093-103. https://doi.org/10.1056/nejmoa035700

583. Li R, Yu K, Li C. Dietary factors and risk of gout and hyperuricemia: a meta-analysis and systematic review. Asia Pac J Clin Nutr. 2018;27(6):1344–56. https://doi.org/10.6133/apjcn.201811_27(6).0022

584. Zgaga L., Theodoratou E., Kyle J. et al. The association of dietary intake of purine-rich vegetables, sugar-sweetened beverages and dairy with plasma urate, in a cross-sectional study. PLoSOne2012;7(6):e38123. https://doi.org/10.1371/journal.pone.0038123

585. Choi H.K., Atkinson K., Karlson E.W. et al. Alcohol intake and risk of incident gout in men: a prospective study. Lancet 2004; 363(9417):1277-81. https://doi.org/10.1016/s0140-6736(04)16000-5

586. Neogi T, Chen C, Niu J et al. Alcohol quantity and type on risk of recurrent gout attacks: an internet-based case-crossover study. Am J Med. 2014;127(4):311-8 https://doi.org/10.1016/j.amjmed.2013.12.019

587. Jamnik J, Rehman S, Blanco Mejia S, et al. Fructose intake And risk of gout and hyperuricemia: a systematic review and meta-analysis of prospective cohort studies. BMJ Open.2016;6(10):e13191 https://doi.org/10.1136/bmjopen-2016-013191

588. Ayoub-Charette S, Liu Q, Khan TA, et al. Important food sources of fructose-containing sugars and incident gout: a systematic review and meta-analysis of prospective cohortstudies. BMJOpen. 2019;9(5):e24171. https://doi.org/10.1136/bmjopen-2018-024171

589. Evans PL, Prior JA, Belcher J et al. Gender-specific risk factors for gout: a systematic review of cohort studies. AdvRheumatol. 2019;59(1):24. https://doi.org/10.1186/s42358-019-0067-7

590. Dalbeth N, Ames R, Gamble G, et al. Effects of skim milk powder enriched with glycomacropeptide and G600 milk fat extract on frequency of gout flares: A proof-of-concept randomised controlled trial. Ann Rheum Dis. 2012 Jun;71(6):929-34. https://doi.org/10.1136/annrheumdis-2011-200156

591. Zhang Y, Yang T, Zeng C, et al. Is coffee consumption associated with a lower risk of hyperuricaemia or gout? A systematic review and meta-analysis. BMJ Open. 2016;6(7):e9809. https://doi.org/10.1136/bmjopen-2015-009809

592. Hillman AR, Uhranowsky K. Acute ingestion of Montmorency tart cherry reduces serum uric acid but has no impact on high sensitivity C-reactive protein or oxidative capacity. Plant Foods Hum Nutr. 2021;76(1):83-89. https://doi.org/10.1007/s11130-021-00879-7

593. Lamb KL, Lynn A, Russell J, Barker ME. Effect of tart cherry juice on risk of gout attacks: protocol for a randomized controlled trial. BMJ Open. 2020;10:e35108. https://doi.org/10.1136/bmjopen-2019-035108